Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:pyranone
go back to main search page
Accession:CHEBI:37963 term browser browse the term
Definition:Any of a class of cyclic chemical compounds that contain an unsaturated six-membered ring with one ring oxygen atom and an oxo substituent.
Synonyms:related_synonym: oxopyrans;   pyranones;   pyrone;   pyrones



show annotations for term's descendants           Sort by:
 
5,6-Dehydrokawain term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases expression ISO 5,6-dehydrokawain results in increased expression of CYP1A1 mRNA CTD PMID:21908763 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
JBrowse link
Citreoviridin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 multiple interactions
decreases phosphorylation
EXP
ISO
Rosiglitazone inhibits the reaction [citreoviridin results in decreased phosphorylation of AKT1 protein]; Sodium Selenite inhibits the reaction [citreoviridin results in decreased phosphorylation of AKT1 protein]; Thiamine inhibits the reaction [citreoviridin results in decreased phosphorylation of AKT1 protein] CTD PMID:31419397 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
JBrowse link
G Aqp7 aquaporin 7 multiple interactions
decreases expression
EXP
ISO
Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of AQP7 mRNA]; Thiamine inhibits the reaction [citreoviridin results in decreased expression of AQP7 mRNA] CTD PMID:31419397 NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
JBrowse link
G Arc activity-regulated cytoskeleton-associated protein increases expression ISO citreoviridin results in increased expression of ARC mRNA CTD PMID:30071239 NCBI chr 7:106,555,968...106,559,697
Ensembl chr 7:106,555,785...106,559,378
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions
ISO
EXP
citreoviridin results in increased expression of BAX protein
Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of BAX protein]; Thiamine inhibits the reaction [citreoviridin results in increased expression of BAX protein]
3-methyladenine inhibits the reaction [citreoviridin results in increased expression of BAX protein]; Rosiglitazone inhibits the reaction [citreoviridin results in increased expression of BAX protein]; Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of BAX protein]; Thiamine inhibits the reaction [citreoviridin results in increased expression of BAX protein]
CTD PMID:31419397 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression
multiple interactions
EXP
ISO
citreoviridin results in decreased expression of BCL2 protein
3-methyladenine inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein]; Rosiglitazone inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein]; Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein]; Thiamine inhibits the reaction [citreoviridin results in decreased expression of BCL2 protein]
CTD PMID:31419397 NCBI chr13:22,689,783...22,853,920 JBrowse link
G Bdnf brain-derived neurotrophic factor affects expression ISO citreoviridin affects the expression of BDNF mRNA CTD PMID:30071239 NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit affects expression ISO citreoviridin affects the expression of CHRNA4 mRNA CTD PMID:30071239 NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit decreases expression ISO citreoviridin results in decreased expression of CHRNA7 mRNA CTD PMID:30071239 NCBI chr 1:116,715,286...116,837,223
Ensembl chr 1:116,714,711...116,837,240
JBrowse link
G Chrnb2 cholinergic receptor nicotinic beta 2 subunit increases expression ISO citreoviridin results in increased expression of CHRNB2 mRNA CTD PMID:30071239 NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:175,181,402...175,189,619
JBrowse link
G Ckb creatine kinase B multiple interactions ISO
EXP
citreoviridin results in increased secretion of [CKM protein binds to CKB protein]; Sodium Selenite inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]; Thiamine inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]
3-methyladenine inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]; citreoviridin results in increased secretion of [CKM protein binds to CKB protein]; Rosiglitazone inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]; Sodium Selenite inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]; Thiamine inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]
CTD PMID:31419397 NCBI chr 6:130,729,420...130,732,301
Ensembl chr 6:130,729,423...130,732,315
JBrowse link
G Ckm creatine kinase, M-type multiple interactions EXP
ISO
3-methyladenine inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]; citreoviridin results in increased secretion of [CKM protein binds to CKB protein]; Rosiglitazone inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]; Sodium Selenite inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]; Thiamine inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]
citreoviridin results in increased secretion of [CKM protein binds to CKB protein]; Sodium Selenite inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]; Thiamine inhibits the reaction [citreoviridin results in increased secretion of [CKM protein binds to CKB protein]]
CTD PMID:31419397 NCBI chr 1:79,061,390...79,071,721
Ensembl chr 1:79,061,456...79,071,720
JBrowse link
G Dcx doublecortin affects expression ISO citreoviridin affects the expression of DCX mRNA CTD PMID:30071239 NCBI chr  X:107,430,767...107,573,612
Ensembl chr  X:107,430,767...107,507,476
JBrowse link
G Eomes eomesodermin increases expression ISO citreoviridin results in increased expression of EOMES mRNA CTD PMID:30071239 NCBI chr 8:118,181,340...118,189,186
Ensembl chr 8:118,181,777...118,188,316
JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions
decreases expression
EXP
ISO
Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA]; Thiamine inhibits the reaction [citreoviridin results in decreased expression of FABP4 mRNA] CTD PMID:31419397 NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578
JBrowse link
G Fgf21 fibroblast growth factor 21 decreases expression ISO citreoviridin results in decreased expression of FGF21 mRNA CTD PMID:28645467 NCBI chr 1:96,083,495...96,084,738
Ensembl chr 1:96,083,441...96,090,454
JBrowse link
G Gfap glial fibrillary acidic protein affects expression ISO citreoviridin affects the expression of GFAP mRNA CTD PMID:30071239 NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 decreases expression ISO citreoviridin results in decreased expression of GRIA1 mRNA CTD PMID:30071239 NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
JBrowse link
G Gria2 glutamate ionotropic receptor AMPA type subunit 2 affects expression ISO citreoviridin affects the expression of GRIA2 mRNA CTD PMID:30071239 NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510
JBrowse link
G Gria3 glutamate ionotropic receptor AMPA type subunit 3 increases expression ISO citreoviridin results in increased expression of GRIA3 mRNA CTD PMID:30071239 NCBI chr  X:120,238,515...120,504,106
Ensembl chr  X:120,238,534...120,504,096
JBrowse link
G Grin2d glutamate ionotropic receptor NMDA type subunit 2D decreases expression ISO citreoviridin results in decreased expression of GRIN2D mRNA CTD PMID:30071239 NCBI chr 1:96,306,871...96,346,994
Ensembl chr 1:96,308,365...96,344,793
JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions
increases expression
ISO
EXP
Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form]; Thiamine inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form]
Rosiglitazone inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form]; Sodium Selenite inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form]; Thiamine inhibits the reaction [citreoviridin results in increased expression of MAP1LC3B protein modified form]
CTD PMID:31419397 NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
JBrowse link
G Neurod1 neuronal differentiation 1 affects expression ISO citreoviridin affects the expression of NEUROD1 mRNA CTD PMID:30071239 NCBI chr 3:64,360,222...64,363,526
Ensembl chr 3:64,359,395...64,363,649
JBrowse link
G Ntrk2 neurotrophic receptor tyrosine kinase 2 increases expression ISO citreoviridin results in increased expression of NTRK2 mRNA CTD PMID:30071239 NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions
decreases activity
EXP Sodium Selenite inhibits the reaction [citreoviridin results in decreased activity of PPARG protein]; Thiamine inhibits the reaction [citreoviridin results in decreased activity of PPARG protein] CTD PMID:31419397 NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
JBrowse link
G Pvalb parvalbumin increases expression ISO citreoviridin results in increased expression of PVALB mRNA CTD PMID:30071239 NCBI chr 7:109,772,939...109,787,954
Ensembl chr 7:109,772,593...109,784,561
JBrowse link
G Slc17a6 solute carrier family 17 member 6 decreases expression ISO citreoviridin results in decreased expression of SLC17A6 mRNA CTD PMID:30071239 NCBI chr 1:101,212,489...101,252,543
Ensembl chr 1:101,212,489...101,252,542
JBrowse link
G Slc17a7 solute carrier family 17 member 7 affects expression ISO citreoviridin affects the expression of SLC17A7 mRNA CTD PMID:30071239 NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588
JBrowse link
G Sox2 SRY-box transcription factor 2 increases expression ISO citreoviridin results in increased expression of SOX2 mRNA CTD PMID:30071239 NCBI chr 2:117,536,929...117,539,338
Ensembl chr 2:117,536,929...117,539,338
JBrowse link
G Sqstm1 sequestosome 1 multiple interactions
decreases expression
ISO
EXP
Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of SQSTM1 protein]; Thiamine inhibits the reaction [citreoviridin results in decreased expression of SQSTM1 protein]
Rosiglitazone inhibits the reaction [citreoviridin results in decreased expression of SQSTM1 protein]; Sodium Selenite inhibits the reaction [citreoviridin results in decreased expression of SQSTM1 protein]; Thiamine inhibits the reaction [citreoviridin results in decreased expression of SQSTM1 protein]
CTD PMID:31419397 NCBI chr10:34,525,517...34,536,685
Ensembl chr10:34,525,519...34,536,673
JBrowse link
G Sst somatostatin increases expression ISO citreoviridin results in increased expression of SST mRNA CTD PMID:30071239 NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173
JBrowse link
G Tnnt2 troponin T2, cardiac type multiple interactions
increases secretion
EXP
ISO
3-methyladenine inhibits the reaction [citreoviridin results in increased secretion of TNNT2 protein]; Rosiglitazone inhibits the reaction [citreoviridin results in increased secretion of TNNT2 protein]; Sodium Selenite inhibits the reaction [citreoviridin results in increased secretion of TNNT2 protein]; Thiamine inhibits the reaction [citreoviridin results in increased secretion of TNNT2 protein] CTD PMID:31419397 NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
JBrowse link
G Vnn1 vanin 1 decreases expression ISO citreoviridin results in decreased expression of VNN1 mRNA CTD PMID:28645467 NCBI chr 1:21,537,084...21,547,395
Ensembl chr 1:21,537,094...21,547,395
JBrowse link
Ethyl maltol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Atm ATM serine/threonine kinase multiple interactions ISO [ethyl maltol results in increased susceptibility to [Copper Sulfate results in increased abundance of Copper]] which results in increased phosphorylation of ATM protein CTD PMID:33271249 NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
JBrowse link
G Ftl1 ferritin light chain 1 multiple interactions ISO [ethyl maltol results in increased susceptibility to [Copper Sulfate results in increased abundance of Copper]] which results in increased expression of FTL mRNA CTD PMID:33271249 NCBI chr 1:95,936,390...95,938,234
Ensembl chr 1:95,936,387...95,939,725
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions ISO [ethyl maltol results in increased susceptibility to [Copper Sulfate results in increased abundance of Copper]] which results in increased expression of HMOX1 mRNA; [ethyl maltol results in increased susceptibility to [Copper Sulfate results in increased abundance of Copper]] which results in increased expression of HMOX1 protein CTD PMID:33271249 NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
JBrowse link
fostriecin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bbc3 Bcl-2 binding component 3 multiple interactions ISO fostriecin inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Benzo(a)pyrene results in increased expression of BBC3 protein]] CTD PMID:24954032 NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
JBrowse link
G Casp3 caspase 3 multiple interactions ISO fostriecin inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Benzo(a)pyrene results in increased cleavage of CASP3 protein]] CTD PMID:24954032 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G Foxo3 forkhead box O3 multiple interactions ISO fostriecin inhibits the reaction [Tetrachlorodibenzodioxin inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of FOXO3 protein]] CTD PMID:24954032 NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
JBrowse link
G Tp53 tumor protein p53 multiple interactions ISO fostriecin promotes the reaction [Tetrachlorodibenzodioxin promotes the reaction [Benzo(a)pyrene results in increased expression of TP53 protein]] CTD PMID:24954032 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
JBrowse link
Goitrin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Gsta2 glutathione S-transferase alpha 2 increases expression
multiple interactions
EXP goitrin results in increased expression of GSTA2 protein
Triiodothyronine inhibits the reaction [goitrin results in increased expression of GSTA2 protein]
CTD PMID:7532609 NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
JBrowse link
G Gstp1 glutathione S-transferase pi 1 decreases expression
multiple interactions
increases expression
EXP goitrin results in decreased expression of GSTP1 protein
Triiodothyronine inhibits the reaction [goitrin results in increased expression of GSTP1 protein]
CTD PMID:7532609 NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
JBrowse link
hispidin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Casp9 caspase 9 multiple interactions
increases activity
EXP hispidin inhibits the reaction [Doxorubicin results in increased activity of CASP9 protein]
hispidin results in increased activity of CASP9 protein
CTD PMID:26318906 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
JBrowse link
G Shc1 SHC adaptor protein 1 multiple interactions EXP hispidin inhibits the reaction [Doxorubicin results in increased expression of and results in decreased phosphorylation of and affects the localization of SHC1 protein] CTD PMID:26318906 NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
JBrowse link
G Smad2 SMAD family member 2 multiple interactions ISO hispidin inhibits the reaction [Cyclosporine results in increased phosphorylation of and results in increased activity of SMAD2 protein] CTD PMID:22155090 NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
JBrowse link
kojic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abca13 ATP binding cassette subfamily A member 13 decreases expression ISO kojic acid results in decreased expression of ABCA13 mRNA CTD PMID:16595896 NCBI chr14:83,873,397...84,376,138
Ensembl chr14:83,873,940...84,375,075
JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of ABCC2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABCC2 mRNA CTD PMID:18544905 NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
JBrowse link
G Abcc6 ATP binding cassette subfamily C member 6 multiple interactions ISO
EXP
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCC6 mRNA
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABCC6 mRNA
CTD PMID:17917374 PMID:18544905 NCBI chr 1:96,447,224...96,501,464
Ensembl chr 1:96,447,251...96,501,464
JBrowse link
G Abcc9 ATP binding cassette subfamily C member 9 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCC9 mRNA CTD PMID:17917374 NCBI chr 4:175,531,854...175,655,849
Ensembl chr 4:175,532,547...175,655,356
JBrowse link
G Abcd1 ATP binding cassette subfamily D member 1 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCD1 mRNA CTD PMID:17917374 NCBI chr  X:151,428,334...151,450,115
Ensembl chr  X:151,428,578...151,450,115
JBrowse link
G Abcf2 ATP binding cassette subfamily F member 2 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid] results in increased expression of ABCF2 mRNA CTD PMID:17917374 NCBI chr 4:10,594,802...10,607,606
Ensembl chr 4:10,594,907...10,607,606
JBrowse link
G Abhd1 abhydrolase domain containing 1 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of ABHD1 mRNA CTD PMID:17917374 NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
JBrowse link
G Acer3 alkaline ceramidase 3 increases expression ISO kojic acid results in increased expression of ACER3 mRNA CTD PMID:16595896 NCBI chr 1:152,504,180...152,606,596
Ensembl chr 1:152,504,186...152,606,591
JBrowse link
G Acmsd aminocarboxymuconate semialdehyde decarboxylase decreases expression ISO kojic acid results in decreased expression of ACMSD mRNA CTD PMID:16595896 NCBI chr13:39,200,486...39,244,337
Ensembl chr13:39,200,314...39,245,209
JBrowse link
G Acvrl1 activin A receptor like type 1 decreases expression ISO kojic acid results in decreased expression of ACVRL1 mRNA CTD PMID:16595896 NCBI chr 7:132,239,200...132,256,592
Ensembl chr 7:132,239,729...132,256,591
JBrowse link
G Adam20 ADAM metallopeptidase domain 20 decreases expression ISO kojic acid results in decreased expression of ADAM20 mRNA CTD PMID:16595896
G Adrb3 adrenoceptor beta 3 decreases expression ISO kojic acid results in decreased expression of ADRB3 mRNA CTD PMID:16595896 NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552
JBrowse link
G Agap3 ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 increases expression ISO kojic acid results in increased expression of AGAP3 mRNA CTD PMID:16595896 NCBI chr 4:10,674,064...10,724,848
Ensembl chr 4:10,674,064...10,725,244
JBrowse link
G Agbl4 AGBL carboxypeptidase 4 decreases expression ISO kojic acid results in decreased expression of AGBL4 mRNA CTD PMID:16595896 NCBI chr 5:125,254,963...126,534,367 JBrowse link
G Ahnak AHNAK nucleoprotein decreases expression ISO kojic acid results in decreased expression of AHNAK mRNA CTD PMID:16595896 NCBI chr 1:205,882,223...205,970,934
Ensembl chr 1:205,882,273...205,970,926
JBrowse link
G Akt1 AKT serine/threonine kinase 1 decreases expression ISO kojic acid results in decreased expression of AKT1 mRNA CTD PMID:16595896 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
JBrowse link
G Alpi alkaline phosphatase, intestinal decreases expression ISO kojic acid results in decreased expression of ALPI mRNA CTD PMID:16595896 NCBI chr 9:87,773,411...87,776,877
Ensembl chr 9:87,773,411...87,776,877
JBrowse link
G Amtn amelotin decreases expression ISO kojic acid results in decreased expression of AMTN mRNA CTD PMID:16595896 NCBI chr14:19,648,624...19,661,181
Ensembl chr14:19,648,625...19,661,181
JBrowse link
G Anxa1 annexin A1 decreases expression ISO kojic acid results in decreased expression of ANXA1 mRNA CTD PMID:16595896 NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
JBrowse link
G Anxa5 annexin A5 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ANXA5 mRNA CTD PMID:17917374 NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
JBrowse link
G Ap1s1 adaptor related protein complex 1 subunit sigma 1 decreases expression ISO kojic acid results in decreased expression of AP1S1 mRNA CTD PMID:16595896 NCBI chr12:19,625,267...19,635,792
Ensembl chr12:19,625,332...19,756,713
JBrowse link
G Apobec1 apolipoprotein B mRNA editing enzyme catalytic subunit 1 decreases expression ISO kojic acid results in decreased expression of APOBEC1 mRNA CTD PMID:16595896 NCBI chr 4:155,800,030...155,828,515
Ensembl chr 4:155,800,887...155,827,390
JBrowse link
G App amyloid beta precursor protein increases expression ISO kojic acid results in increased expression of APP mRNA CTD PMID:16595896 NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
JBrowse link
G Aptx aprataxin decreases expression ISO kojic acid results in decreased expression of APTX mRNA CTD PMID:16595896 NCBI chr 5:55,798,896...55,822,963
Ensembl chr 5:55,800,248...55,822,855
JBrowse link
G Aqp1 aquaporin 1 increases expression ISO kojic acid results in increased expression of AQP1 mRNA CTD PMID:16595896 NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
JBrowse link
G Arfip2 ADP-ribosylation factor interacting protein 2 decreases expression ISO kojic acid results in decreased expression of ARFIP2 mRNA CTD PMID:16595896 NCBI chr 1:159,974,255...159,980,398
Ensembl chr 1:159,974,201...159,980,336
JBrowse link
G Arhgef16 Rho guanine nucleotide exchange factor 16 decreases expression ISO kojic acid results in decreased expression of ARHGEF16 mRNA CTD PMID:16595896 NCBI chr 5:164,843,656...164,866,212
Ensembl chr 5:164,844,161...164,866,212
JBrowse link
G Arl6ip5 ADP-ribosylation factor like GTPase 6 interacting protein 5 increases expression ISO kojic acid results in increased expression of ARL6IP5 mRNA CTD PMID:16595896 NCBI chr 4:129,810,650...129,838,628
Ensembl chr 4:129,810,645...129,838,608
JBrowse link
G Asnsd1 asparagine synthetase domain containing 1 decreases expression ISO kojic acid results in decreased expression of ASNSD1 mRNA CTD PMID:16595896 NCBI chr 9:48,126,802...48,139,073
Ensembl chr 9:48,126,808...48,139,073
JBrowse link
G Atf6b activating transcription factor 6 beta decreases expression ISO kojic acid results in decreased expression of ATF6B mRNA CTD PMID:16595896 NCBI chr20:4,090,921...4,098,920
Ensembl chr20:4,090,921...4,098,894
JBrowse link
G Atm ATM serine/threonine kinase multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ATM mRNA CTD PMID:17917374 NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
JBrowse link
G B4galnt4 beta-1,4-N-acetyl-galactosaminyl transferase 4 decreases expression ISO kojic acid results in decreased expression of B4GALNT4 mRNA CTD PMID:16595896 NCBI chr 1:196,171,394...196,182,294
Ensembl chr 1:196,171,394...196,182,294
JBrowse link
G Bag5 BAG cochaperone 5 decreases expression ISO kojic acid results in decreased expression of BAG5 mRNA CTD PMID:16595896 NCBI chr 6:130,768,467...130,772,122
Ensembl chr 6:130,768,141...130,772,970
JBrowse link
G Bcl2a1 BCL2-related protein A1 increases expression ISO kojic acid results in increased expression of BCL2A1 mRNA CTD PMID:16595896 NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
JBrowse link
G Bcl2l2 Bcl2-like 2 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of BCL2L2 mRNA CTD PMID:17917374 NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624
JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 decreases expression ISO kojic acid results in decreased expression of BIRC2 mRNA CTD PMID:16595896 NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
JBrowse link
G Bmp5 bone morphogenetic protein 5 decreases expression ISO kojic acid results in decreased expression of BMP5 mRNA CTD PMID:16595896 NCBI chr 8:76,517,164...76,639,925
Ensembl chr 8:76,517,164...76,639,925
JBrowse link
G Brsk1 BR serine/threonine kinase 1 decreases expression ISO kojic acid results in decreased expression of BRSK1 mRNA CTD PMID:16595896 NCBI chr 1:69,134,166...69,159,947
Ensembl chr 1:69,134,565...69,160,365
JBrowse link
G Bst2 bone marrow stromal cell antigen 2 decreases expression ISO kojic acid results in decreased expression of BST2 mRNA CTD PMID:16595896 NCBI chr16:18,217,404...18,220,979
Ensembl chr16:18,217,407...18,220,979
JBrowse link
G C2H1orf54 chromosome 2 C1orf54 homolog increases expression ISO kojic acid results in increased expression of C1ORF54 mRNA CTD PMID:16595896 NCBI chr 2:183,424,989...183,434,773 JBrowse link
G Ca13 carbonic anhydrase 13 increases expression ISO kojic acid results in increased expression of CAR13 mRNA CTD PMID:19000923 NCBI chr 2:86,928,401...86,959,525
Ensembl chr 2:86,928,383...86,959,525
JBrowse link
G Ca14 carbonic anhydrase 14 increases expression ISO kojic acid results in increased expression of CA14 mRNA CTD PMID:16595896 NCBI chr 2:183,442,263...183,449,207
Ensembl chr 2:183,441,667...183,449,693
JBrowse link
G Cab39l calcium binding protein 39-like increases expression ISO kojic acid results in increased expression of CAB39L mRNA CTD PMID:16595896 NCBI chr15:33,606,588...33,710,518
Ensembl chr15:33,606,694...33,743,545
JBrowse link
G Calr calreticulin multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CALR mRNA CTD PMID:18544905 NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
JBrowse link
G Casp4 caspase 4 multiple interactions EXP [kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CASP4 mRNA] CTD PMID:18544905 NCBI chr 8:2,599,017...2,635,097
Ensembl chr 8:2,598,876...2,635,092
JBrowse link
G Casp8 caspase 8 multiple interactions EXP [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CASP8 mRNA CTD PMID:18544905 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
JBrowse link
G Cat catalase multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CAT mRNA CTD PMID:18544905 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
JBrowse link
G Ccar1 cell division cycle and apoptosis regulator 1 increases expression ISO kojic acid results in increased expression of CCAR1 mRNA CTD PMID:16595896 NCBI chr20:30,685,916...30,728,531
Ensembl chr20:30,685,916...30,728,526
JBrowse link
G Ccdc50 coiled-coil domain containing 50 increases expression ISO kojic acid results in increased expression of CCDC50 mRNA CTD PMID:16595896 NCBI chr11:73,332,798...73,395,333
Ensembl chr11:73,334,248...73,395,150
JBrowse link
G Ccl21 C-C motif chemokine ligand 21 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCL21A mRNA CTD PMID:17917374 NCBI chr 5:56,980,557...56,981,661
Ensembl chr 5:56,980,558...56,981,686
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCL3 mRNA CTD PMID:17917374 NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
JBrowse link
G Ccnb1 cyclin B1 increases expression ISO kojic acid results in increased expression of CCNB1 mRNA CTD PMID:19000923 NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
JBrowse link
G Ccnc cyclin C multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCNC mRNA CTD PMID:17917374 NCBI chr 5:35,266,828...35,284,943
Ensembl chr 5:35,266,823...35,296,584
JBrowse link
G Ccnd1 cyclin D1 multiple interactions EXP
ISO
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CCND1 mRNA
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCND1 mRNA
CTD PMID:17917374 PMID:18544905 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
JBrowse link
G Ccng1 cyclin G1 multiple interactions EXP
ISO
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of CCNG1 mRNA
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CCNG1 mRNA
CTD PMID:17917374 PMID:18544905 NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
JBrowse link
G Ccpg1 cell cycle progression 1 decreases expression ISO kojic acid results in decreased expression of CCPG1 mRNA CTD PMID:16595896 NCBI chr 8:73,719,960...73,752,437
Ensembl chr 8:73,719,955...73,752,430
JBrowse link
G Ccr4 C-C motif chemokine receptor 4 decreases expression ISO kojic acid results in decreased expression of CCR4 mRNA CTD PMID:16595896 NCBI chr 8:114,176,256...114,182,155
Ensembl chr 8:114,176,974...114,178,056
JBrowse link
G Cd22 CD22 molecule decreases expression ISO kojic acid results in decreased expression of CD22 mRNA CTD PMID:16595896 NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
JBrowse link
G Cd274 CD274 molecule increases expression ISO kojic acid results in increased expression of CD274 mRNA CTD PMID:16595896 NCBI chr 1:227,116,627...227,137,379
Ensembl chr 1:227,116,649...227,134,450
JBrowse link
G Cd3g CD3g molecule decreases expression ISO kojic acid results in decreased expression of CD3G mRNA CTD PMID:16595896 NCBI chr 8:45,280,797...45,287,271
Ensembl chr 8:45,281,204...45,287,147
JBrowse link
G Cdin1 CDAN1 interacting nuclease 1 increases expression ISO kojic acid results in increased expression of CDIN1 mRNA CTD PMID:16595896 NCBI chr 3:102,441,553...102,646,935
Ensembl chr 3:102,441,704...102,646,682
JBrowse link
G Cdk10 cyclin-dependent kinase 10 decreases expression ISO kojic acid results in decreased expression of CDK10 mRNA CTD PMID:16595896 NCBI chr19:51,260,012...51,273,009
Ensembl chr19:51,261,356...51,269,078
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions ISO
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CDKN1A mRNA
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of CDKN1A mRNA
CTD PMID:17917374 PMID:18544905 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions EXP [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA; [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA CTD PMID:18544905 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
JBrowse link
G Ceacam1 CEA cell adhesion molecule 1 decreases expression ISO kojic acid results in decreased expression of CEACAM1 mRNA CTD PMID:16595896 NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
JBrowse link
G Cebpd CCAAT/enhancer binding protein delta increases expression ISO kojic acid results in increased expression of CEBPD mRNA CTD PMID:16595896 NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
JBrowse link
G Cenpq centromere protein Q decreases expression ISO kojic acid results in decreased expression of CENPQ mRNA CTD PMID:16595896 NCBI chr 9:19,957,040...19,972,807 JBrowse link
G Cep192 centrosomal protein 192 increases expression ISO kojic acid results in increased expression of CEP192 mRNA CTD PMID:16595896 NCBI chr18:61,346,957...61,458,405
Ensembl chr18:61,332,158...61,458,379
JBrowse link
G Cep72 centrosomal protein 72 increases expression ISO kojic acid results in increased expression of CEP72 mRNA CTD PMID:16595896 NCBI chr 1:29,225,312...29,255,294
Ensembl chr 1:29,225,361...29,255,271
JBrowse link
G Ces1d carboxylesterase 1D multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CES1 mRNA CTD PMID:18544905 NCBI chr19:13,873,490...13,912,035 JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions EXP [kojic acid co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of CHEK2 mRNA] CTD PMID:18544905 NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
JBrowse link
G Chst4 carbohydrate sulfotransferase 4 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CHST4 mRNA CTD PMID:17917374 NCBI chr19:37,993,471...38,002,123
Ensembl chr19:37,991,417...38,003,608
JBrowse link
G Cibar1 CBY1 interacting BAR domain containing 1 increases expression ISO kojic acid results in increased expression of CIBAR1 mRNA CTD PMID:16595896 NCBI chr 5:25,613,993...25,632,440
Ensembl chr 5:25,614,033...25,632,489
JBrowse link
G Cldn3 claudin 3 decreases expression ISO kojic acid results in decreased expression of CLDN3 mRNA CTD PMID:16595896 NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
JBrowse link
G Cldnd2 claudin domain containing 2 decreases expression ISO kojic acid results in decreased expression of CLDND2 mRNA CTD PMID:16595896 NCBI chr 1:93,848,533...93,851,693
Ensembl chr 1:93,848,533...93,851,217
JBrowse link
G Clec4b2 C-type lectin domain family 4, member B2 decreases expression ISO kojic acid results in decreased expression of CLEC4C mRNA CTD PMID:16595896 NCBI chr 4:156,462,742...156,486,240
Ensembl chr 4:156,462,742...156,486,240
JBrowse link
G Clmp CXADR-like membrane protein decreases expression ISO kojic acid results in decreased expression of CLMP mRNA CTD PMID:16595896 NCBI chr 8:41,060,527...41,168,841
Ensembl chr 8:41,060,799...41,168,838
JBrowse link
G Clu clusterin multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CLU mRNA CTD PMID:18544905 NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
JBrowse link
G Cnih1 cornichon family AMPA receptor auxiliary protein 1 increases expression ISO kojic acid results in increased expression of CNIH1 mRNA CTD PMID:16595896 NCBI chr15:20,037,885...20,049,857
Ensembl chr15:20,037,885...20,049,761
JBrowse link
G Cnksr2 connector enhancer of kinase suppressor of Ras 2 decreases expression ISO kojic acid results in decreased expression of CNKSR2 mRNA CTD PMID:16595896 NCBI chr  X:36,908,135...37,148,337
Ensembl chr  X:36,907,850...37,150,555
JBrowse link
G Col17a1 collagen type XVII alpha 1 chain decreases expression ISO kojic acid results in decreased expression of COL17A1 mRNA CTD PMID:16595896 NCBI chr 1:246,530,589...246,577,632
Ensembl chr 1:246,531,367...246,577,632
JBrowse link
G Col24a1 collagen type XXIV alpha 1 chain decreases expression ISO kojic acid results in decreased expression of COL24A1 mRNA CTD PMID:16595896 NCBI chr 2:234,212,256...234,469,445
Ensembl chr 2:234,212,324...234,469,441
JBrowse link
G Colq collagen like tail subunit of asymmetric acetylcholinesterase increases expression ISO kojic acid results in increased expression of COLQ mRNA CTD PMID:16595896 NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
JBrowse link
G Comt catechol-O-methyltransferase multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of COMT mRNA CTD PMID:18544905 NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
JBrowse link
G Cops2 COP9 signalosome subunit 2 decreases expression ISO kojic acid results in decreased expression of COPS2 mRNA CTD PMID:16595896 NCBI chr 3:113,084,174...113,110,090
Ensembl chr 3:113,084,176...113,109,947
JBrowse link
G Coq10a coenzyme Q10A increases expression ISO kojic acid results in increased expression of COQ10A mRNA CTD PMID:16595896 NCBI chr 7:792,089...798,392
Ensembl chr 7:792,089...800,161
JBrowse link
G Coq8a coenzyme Q8A increases expression ISO kojic acid results in increased expression of COQ8A mRNA CTD PMID:16595896 NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431
JBrowse link
G Cpb1 carboxypeptidase B1 decreases expression ISO kojic acid results in decreased expression of CPB1 mRNA CTD PMID:16595896 NCBI chr 2:102,755,241...102,785,628
Ensembl chr 2:102,755,241...102,785,628
JBrowse link
G Cpe carboxypeptidase E increases expression ISO kojic acid results in increased expression of CPE mRNA CTD PMID:16595896 NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
JBrowse link
G Cpne5 copine 5 increases expression ISO kojic acid results in increased expression of CPNE5 mRNA CTD PMID:16595896 NCBI chr20:7,206,742...7,289,309
Ensembl chr20:7,206,742...7,288,883
JBrowse link
G Creb1 cAMP responsive element binding protein 1 decreases phosphorylation ISO kojic acid results in decreased phosphorylation of CREB1 protein CTD PMID:27586645 NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
JBrowse link
G Cse1l chromosome segregation 1 like decreases expression ISO kojic acid results in decreased expression of CSE1L mRNA CTD PMID:16595896 NCBI chr 3:155,641,104...155,678,866
Ensembl chr 3:155,641,166...155,678,865
JBrowse link
G Ctnnal1 catenin alpha-like 1 decreases expression ISO kojic acid results in decreased expression of CTNNAL1 mRNA CTD PMID:16595896 NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431
JBrowse link
G Ctsz cathepsin Z increases expression ISO kojic acid results in increased expression of CTSZ mRNA CTD PMID:16595896 NCBI chr 3:163,224,875...163,235,645
Ensembl chr 3:163,224,875...163,235,645
JBrowse link
G Cyb5r3 cytochrome b5 reductase 3 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYB5R3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYB5R3 mRNA CTD PMID:18544905 NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 increases expression ISO kojic acid results in increased expression of CYP26B1 mRNA CTD PMID:16595896 NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2A5 mRNA CTD PMID:17917374 NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979
JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B10 mRNA CTD PMID:17917374 NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
JBrowse link
G Cyp2b15 cytochrome P450, family 2, subfamily b, polypeptide 15 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2B15 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2B15 mRNA CTD PMID:18544905 NCBI chr 1:82,094,188...82,106,492
Ensembl chr 1:82,094,180...82,106,492
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP2B9 mRNA CTD PMID:17917374 NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
JBrowse link
G Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C mRNA CTD PMID:18544905 NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
JBrowse link
G Cyp2c13 cytochrome P450, family 2, subfamily c, polypeptide 13 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C13 mRNA CTD PMID:18544905 NCBI chr 1:238,786,764...238,867,195
Ensembl chr 1:238,786,765...238,867,191
JBrowse link
G Cyp2c7 cytochrome P450, family 2, subfamily c, polypeptide 7 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2C7 mRNA CTD PMID:18544905 NCBI chr 1:237,332,641...237,388,714
Ensembl chr 1:237,332,659...237,388,709
JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2D22 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2D22 mRNA CTD PMID:18544905 NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2E1 mRNA CTD PMID:18544905 NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
JBrowse link
G Cyp2f4 cytochrome P450, family 2, subfamily f, polypeptide 4 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP2F2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP2F2 mRNA CTD PMID:18544905 NCBI chr 1:82,416,108...82,429,897
Ensembl chr 1:82,416,130...82,429,896
JBrowse link
G Cyp4a1 cytochrome P450, family 4, subfamily a, polypeptide 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4A22 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP4A22 mRNA CTD PMID:18544905 NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 multiple interactions ISO
EXP
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of CYP4B1 mRNA
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4B1 mRNA
CTD PMID:17917374 PMID:18544905 NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
JBrowse link
G Cyp4f1 cytochrome P450, family 4, subfamily f, polypeptide 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4F2 mRNA CTD PMID:18544905 NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP7A1 mRNA CTD PMID:17917374 NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
JBrowse link
G Cyp8b1 cytochrome P450 family 8 subfamily B member 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP8B1 mRNA CTD PMID:18544905 NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
JBrowse link
G Cyth3 cytohesin 3 increases expression ISO kojic acid results in increased expression of CYTH3 mRNA CTD PMID:16595896 NCBI chr12:10,840,137...10,933,792
Ensembl chr12:10,840,157...10,933,812
JBrowse link
G Cytip cytohesin 1 interacting protein increases expression ISO kojic acid results in increased expression of CYTIP mRNA CTD PMID:16595896 NCBI chr 3:42,698,058...42,774,955
Ensembl chr 3:42,698,768...42,725,993
JBrowse link
G Dagla diacylglycerol lipase, alpha increases expression ISO kojic acid results in increased expression of DAGLA mRNA CTD PMID:16595896 NCBI chr 1:206,890,635...206,947,332
Ensembl chr 1:206,890,638...206,947,232
JBrowse link
G Dazap2 DAZ associated protein 2 increases expression ISO kojic acid results in increased expression of DAZAP2 mRNA CTD PMID:16595896 NCBI chr 7:131,714,723...131,720,266
Ensembl chr 7:131,714,745...131,720,265
JBrowse link
G Dcaf13 DDB1 and CUL4 associated factor 13 decreases expression ISO kojic acid results in decreased expression of DCAF13 mRNA CTD PMID:16595896 NCBI chr 7:70,160,983...70,196,142
Ensembl chr 7:70,160,941...70,196,142
JBrowse link
G Dct dopachrome tautomerase decreases expression ISO kojic acid results in decreased expression of DCT protein CTD PMID:27586645 NCBI chr15:95,062,006...95,100,863
Ensembl chr15:95,062,003...95,100,836
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions EXP [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DDIT3 mRNA CTD PMID:18544905 NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
JBrowse link
G Dek DEK proto-oncogene decreases expression ISO kojic acid results in decreased expression of DEK mRNA CTD PMID:16595896 NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
JBrowse link
G Dlgap4 DLG associated protein 4 increases expression ISO kojic acid results in increased expression of DLGAP4 mRNA CTD PMID:16595896 NCBI chr 3:145,124,189...145,271,791
Ensembl chr 3:145,175,479...145,270,490
JBrowse link
G Dlx1 distal-less homeobox 1 decreases expression ISO kojic acid results in decreased expression of DLX1 mRNA CTD PMID:16595896 NCBI chr 3:56,356,190...56,360,780
Ensembl chr 3:56,356,190...56,360,780
JBrowse link
G Dmxl1 Dmx-like 1 decreases expression ISO kojic acid results in decreased expression of DMXL1 mRNA CTD PMID:16595896 NCBI chr18:42,993,292...43,163,457
Ensembl chr18:42,993,340...43,163,456
JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DNAJA1 mRNA CTD PMID:18544905 NCBI chr 5:55,842,414...55,853,326
Ensembl chr 5:55,842,426...55,853,967
JBrowse link
G Dnaja2 DnaJ heat shock protein family (Hsp40) member A2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of DNAJA2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of DNAJA2 mRNA CTD PMID:18544905 NCBI chr19:21,497,792...21,516,904
Ensembl chr19:21,497,729...21,516,901
JBrowse link
G Dnttip2 deoxynucleotidyltransferase, terminal, interacting protein 2 decreases expression ISO kojic acid results in decreased expression of DNTTIP2 mRNA CTD PMID:16595896 NCBI chr 2:210,374,240...210,386,366
Ensembl chr 2:210,374,289...210,385,581
JBrowse link
G Dock4 dedicator of cytokinesis 4 increases expression ISO kojic acid results in increased expression of DOCK4 mRNA CTD PMID:16595896 NCBI chr 6:57,512,929...57,902,597
Ensembl chr 6:57,512,908...57,901,855
JBrowse link
G Dok4 docking protein 4 decreases expression ISO kojic acid results in decreased expression of DOK4 mRNA CTD PMID:16595896 NCBI chr19:10,146,520...10,157,187
Ensembl chr19:10,146,474...10,158,203
JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid] results in increased expression of DPYD mRNA CTD PMID:18544905 NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
JBrowse link
G Dspp dentin sialophosphoprotein decreases expression ISO kojic acid results in decreased expression of DSPP mRNA CTD PMID:16595896 NCBI chr14:5,565,562...5,571,669
Ensembl chr14:5,565,629...5,571,672
JBrowse link
G Dstn destrin, actin depolymerizing factor increases expression ISO kojic acid results in increased expression of DSTN mRNA CTD PMID:16595896 NCBI chr 3:131,284,647...131,311,361
Ensembl chr 3:131,284,648...131,311,379
JBrowse link
G Dynlt3 dynein light chain Tctex-type 3 decreases expression ISO kojic acid results in decreased expression of DYNLT3 mRNA CTD PMID:16595896 NCBI chr  X:13,327,933...13,337,139
Ensembl chr  X:13,327,892...13,337,139
JBrowse link
G E2f3 E2F transcription factor 3 increases expression ISO kojic acid results in increased expression of E2F3 mRNA CTD PMID:16595896 NCBI chr17:34,601,756...34,679,139
Ensembl chr17:34,601,830...34,676,253
JBrowse link
G E2f8 E2F transcription factor 8 increases expression ISO kojic acid results in increased expression of E2F8 mRNA CTD PMID:16595896 NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
JBrowse link
G Efna3 ephrin A3 decreases expression ISO kojic acid results in decreased expression of EFNA3 mRNA CTD PMID:16595896 NCBI chr 2:174,729,192...174,738,111
Ensembl chr 2:174,729,764...174,738,736
JBrowse link
G Egr1 early growth response 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of EGR1 mRNA CTD PMID:18544905 NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
JBrowse link
G Eif4e eukaryotic translation initiation factor 4E decreases expression ISO kojic acid results in decreased expression of EIF4E mRNA CTD PMID:16595896 NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
JBrowse link
G Eif5a2 eukaryotic translation initiation factor 5A2 increases expression ISO kojic acid results in increased expression of EIF5A2 mRNA CTD PMID:16595896 NCBI chr 2:111,728,587...111,746,087
Ensembl chr 2:111,729,323...111,746,087
JBrowse link
G Elane elastase, neutrophil expressed decreases expression ISO kojic acid results in decreased expression of ELANE mRNA CTD PMID:16595896 NCBI chr 7:9,817,251...9,819,174
Ensembl chr 7:9,817,252...9,819,100
JBrowse link
G Ep300 E1A binding protein p300 increases expression ISO kojic acid results in increased expression of EP300 mRNA CTD PMID:16595896 NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088
JBrowse link
G Epha10 EPH receptor A10 decreases expression ISO kojic acid results in decreased expression of EPHA10 mRNA CTD PMID:16595896 NCBI chr 5:137,139,588...137,175,637
Ensembl chr 5:137,140,735...137,174,157
JBrowse link
G Epha4 Eph receptor A4 increases expression ISO kojic acid results in increased expression of EPHA4 mRNA CTD PMID:16595896 NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139
JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX1 mRNA CTD PMID:18544905 NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
JBrowse link
G Ephx2 epoxide hydrolase 2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of EPHX2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of EPHX2 mRNA CTD PMID:18544905 NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615
JBrowse link
G Ercc2 ERCC excision repair 2, TFIIH core complex helicase subunit multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC2 mRNA CTD PMID:17917374 NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
JBrowse link
G Ercc3 ERCC excision repair 3, TFIIH core complex helicase subunit multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of ERCC3 mRNA CTD PMID:18544905 NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329
JBrowse link
G Ercc4 ERCC excision repair 4, endonuclease catalytic subunit multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC4 mRNA CTD PMID:17917374 NCBI chr10:2,416,259...2,448,364 JBrowse link
G Ercc5 ERCC excision repair 5, endonuclease multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of ERCC5 mRNA CTD PMID:17917374 NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
JBrowse link
G Esam endothelial cell adhesion molecule increases expression ISO kojic acid results in increased expression of ESAM mRNA CTD PMID:16595896 NCBI chr 8:37,238,228...37,249,217
Ensembl chr 8:37,238,287...37,249,215
JBrowse link
G Esrp1 epithelial splicing regulatory protein 1 increases expression ISO kojic acid results in increased expression of ESRP1 mRNA CTD PMID:16595896 NCBI chr 5:24,427,611...24,482,157
Ensembl chr 5:24,428,717...24,482,062
JBrowse link
G Exd1 exonuclease 3'-5' domain containing 1 decreases expression ISO kojic acid results in decreased expression of EXD1 mRNA CTD PMID:16595896 NCBI chr 3:106,507,839...106,535,922
Ensembl chr 3:106,508,076...106,535,922
JBrowse link
G Exoc2 exocyst complex component 2 increases expression ISO kojic acid results in increased expression of EXOC2 mRNA CTD PMID:16595896 NCBI chr17:33,506,289...33,698,246
Ensembl chr17:33,506,338...33,693,289
JBrowse link
G F10 coagulation factor X increases expression ISO kojic acid results in increased expression of F10 mRNA CTD PMID:16595896 NCBI chr16:76,468,834...76,488,141
Ensembl chr16:76,468,838...76,488,141
JBrowse link
G Fam241a family with sequence similarity 241 member A increases expression ISO kojic acid results in increased expression of FAM241A mRNA CTD PMID:16595896 NCBI chr 2:216,344,563...216,375,193
Ensembl chr 2:216,343,822...216,375,242
JBrowse link
G Fbn2 fibrillin 2 increases expression ISO kojic acid results in increased expression of FBN2 mRNA CTD PMID:16595896 NCBI chr18:51,499,737...51,703,976
Ensembl chr18:51,499,737...51,703,976
JBrowse link
G Fbxo16 F-box protein 16 increases expression ISO kojic acid results in increased expression of FBXO16 mRNA CTD PMID:16595896 NCBI chr15:39,492,268...39,541,493
Ensembl chr15:39,492,377...39,541,480
JBrowse link
G Fgf12 fibroblast growth factor 12 increases expression ISO kojic acid results in increased expression of FGF12 mRNA CTD PMID:16595896 NCBI chr11:71,997,049...72,564,965
Ensembl chr11:71,997,099...72,562,607
JBrowse link
G Fgf5 fibroblast growth factor 5 decreases expression ISO kojic acid results in decreased expression of FGF5 mRNA CTD PMID:16595896 NCBI chr14:11,325,334...11,346,570
Ensembl chr14:11,325,334...11,345,997
JBrowse link
G Fgfr3 fibroblast growth factor receptor 3 decreases expression ISO kojic acid results in decreased expression of FGFR3 mRNA CTD PMID:16595896 NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
JBrowse link
G Fibcd1 fibrinogen C domain containing 1 decreases expression ISO kojic acid results in decreased expression of FIBCD1 mRNA CTD PMID:16595896 NCBI chr 3:15,092,681...15,126,399
Ensembl chr 3:15,092,681...15,126,399
JBrowse link
G Fkbp10 FKBP prolyl isomerase 10 increases expression ISO kojic acid results in increased expression of FKBP10 mRNA CTD PMID:16595896 NCBI chr10:85,345,434...85,357,998
Ensembl chr10:85,346,126...85,427,330
JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of FMO1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of FMO1 mRNA CTD PMID:18544905 NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
JBrowse link
G Fpgt fucose-1-phosphate guanylyltransferase decreases expression ISO kojic acid results in decreased expression of FPGT mRNA CTD PMID:16595896 NCBI chr 2:244,099,031...244,119,967
Ensembl chr 2:244,099,076...244,119,899
JBrowse link
G Frmpd4 FERM and PDZ domain containing 4 decreases expression ISO kojic acid results in decreased expression of FRMPD4 mRNA CTD PMID:16595896 NCBI chr  X:25,853,849...26,814,642
Ensembl chr  X:25,853,934...26,814,637
JBrowse link
G Fzd8 frizzled class receptor 8 increases expression ISO kojic acid results in increased expression of FZD8 mRNA CTD PMID:16595896 NCBI chr17:57,312,924...57,320,551
Ensembl chr17:57,314,450...57,320,650
JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible, beta multiple interactions EXP [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GADD45B mRNA CTD PMID:18544905 NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
JBrowse link
G Galnt1 polypeptide N-acetylgalactosaminyltransferase 1 decreases expression ISO kojic acid results in decreased expression of GALNT1 mRNA CTD PMID:16595896 NCBI chr18:15,489,015...15,568,849
Ensembl chr18:15,489,020...15,568,245
JBrowse link
G Gfod1 glucose-fructose oxidoreductase domain containing 1 decreases expression ISO kojic acid results in decreased expression of GFOD1 mRNA CTD PMID:16595896 NCBI chr17:21,400,142...21,504,972
Ensembl chr17:21,399,479...21,499,938
JBrowse link
G Gle1 GLE1 RNA export mediator decreases expression ISO kojic acid results in decreased expression of GLE1 mRNA CTD PMID:16595896 NCBI chr 3:13,209,312...13,237,018
Ensembl chr 3:13,209,322...13,237,379
JBrowse link
G Gmpr guanosine monophosphate reductase decreases expression ISO kojic acid results in decreased expression of GMPR mRNA CTD PMID:16595896 NCBI chr17:19,151,820...19,189,626
Ensembl chr17:19,151,815...19,189,621
JBrowse link
G Gnb1 G protein subunit beta 1 increases expression ISO kojic acid results in increased expression of GNB1 mRNA CTD PMID:16595896 NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
JBrowse link
G Gpr146 G protein-coupled receptor 146 decreases expression ISO kojic acid results in decreased expression of GPR146 mRNA CTD PMID:16595896 NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206
JBrowse link
G Gpr26 G protein-coupled receptor 26 decreases expression ISO kojic acid results in decreased expression of GPR26 mRNA CTD PMID:16595896 NCBI chr 1:186,766,001...186,805,435
Ensembl chr 1:186,767,062...186,784,568
JBrowse link
G Gpr32 G protein-coupled receptor 32 increases expression ISO kojic acid results in increased expression of GPR32 mRNA CTD PMID:16595896 NCBI chr 1:94,756,863...94,757,895 JBrowse link
G Gpr61 G protein-coupled receptor 61 decreases expression ISO kojic acid results in decreased expression of GPR61 mRNA CTD PMID:16595896 NCBI chr 2:195,781,931...195,789,798
Ensembl chr 2:195,782,752...195,789,621
JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GPX1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GPX1 mRNA CTD PMID:18544905 NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
JBrowse link
G Gsdma gasdermin A decreases expression ISO kojic acid results in decreased expression of GSDMA mRNA CTD PMID:16595896 NCBI chr10:83,614,336...83,639,543
Ensembl chr10:83,627,051...83,639,543
JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of GSR mRNA CTD PMID:17917374 NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
JBrowse link
G Gsta1 glutathione S-transferase alpha 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTA3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA3 mRNA CTD PMID:18544905 NCBI chr 9:23,703,476...23,720,121
Ensembl chr 9:23,703,477...23,720,121
JBrowse link
G Gsta2 glutathione S-transferase alpha 2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTA2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA2 mRNA CTD PMID:18544905 NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
JBrowse link
G Gsta4 glutathione S-transferase alpha 4 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA4 mRNA CTD PMID:18544905 NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182
JBrowse link
G Gstm1 glutathione S-transferase mu 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM1 mRNA CTD PMID:18544905 NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
JBrowse link
G Gstm2 glutathione S-transferase mu 2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM2 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM2 mRNA CTD PMID:18544905 NCBI chr 2:195,624,015...195,628,774 JBrowse link
G Gstm5 glutathione S-transferase, mu 5 multiple interactions ISO
EXP
[Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM3 mRNA
CTD PMID:17917374 PMID:18544905 NCBI chr 2:195,531,627...195,534,562
Ensembl chr 2:195,531,495...195,534,553
JBrowse link
G Gucy1a2 guanylate cyclase 1 soluble subunit alpha 2 decreases expression ISO kojic acid results in decreased expression of GUCY1A2 mRNA CTD PMID:16595896 NCBI chr 8:500,212...900,201
Ensembl chr 8:500,212...889,203
JBrowse link
G H1f1 H1.1 linker histone, cluster member increases expression ISO kojic acid results in increased expression of H1-1 mRNA CTD PMID:16595896 NCBI chr17:41,366,268...41,367,011
Ensembl chr17:41,366,268...41,367,011
JBrowse link
G Hand1 heart and neural crest derivatives expressed 1 increases expression ISO kojic acid results in increased expression of HAND1 mRNA CTD PMID:16595896 NCBI chr10:42,006,646...42,009,213
Ensembl chr10:42,006,651...42,009,213
JBrowse link
G Harbi1 harbinger transposase derived 1 decreases expression ISO kojic acid results in decreased expression of HARBI1 mRNA CTD PMID:16595896 NCBI chr 3:77,681,431...77,689,749
Ensembl chr 3:77,681,431...77,689,724
JBrowse link
G Hibch 3-hydroxyisobutyryl-CoA hydrolase decreases expression ISO kojic acid results in decreased expression of HIBCH mRNA CTD PMID:16595896 NCBI chr 9:48,590,097...48,669,896
Ensembl chr 9:48,590,099...48,669,824
JBrowse link
G Hint3 histidine triad nucleotide binding protein 3 increases expression ISO kojic acid results in increased expression of HINT3 mRNA CTD PMID:16595896 NCBI chr 1:27,035,936...27,045,799
Ensembl chr 1:27,035,905...27,047,721
JBrowse link
G Hip1 huntingtin interacting protein 1 increases expression ISO kojic acid results in increased expression of HIP1 mRNA CTD PMID:16595896 NCBI chr12:21,133,319...21,267,796
Ensembl chr12:21,133,406...21,267,725
JBrowse link
G Hlf HLF transcription factor, PAR bZIP family member decreases expression ISO kojic acid results in decreased expression of HLF mRNA CTD PMID:16595896 NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935
JBrowse link
G Hmmr hyaluronan-mediated motility receptor decreases expression ISO kojic acid results in decreased expression of HMMR mRNA CTD PMID:16595896 NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
JBrowse link
G Hmox2 heme oxygenase 2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HMOX2 mRNA CTD PMID:18544905 NCBI chr10:10,797,076...10,831,178
Ensembl chr10:10,797,055...10,831,148
JBrowse link
G Hnrnph2 heterogeneous nuclear ribonucleoprotein H2 increases expression ISO kojic acid results in increased expression of HNRNPH2 mRNA CTD PMID:16595896 NCBI chr  X:97,780,890...97,786,846
Ensembl chr  X:97,780,785...97,787,041
JBrowse link
G Hps3 HPS3, biogenesis of lysosomal organelles complex 2 subunit 1 decreases expression ISO kojic acid results in decreased expression of HPS3 mRNA CTD PMID:16595896 NCBI chr 2:102,484,574...102,527,580
Ensembl chr 2:102,484,574...102,526,047
JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSP90AA1 mRNA CTD PMID:18544905 NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSP90AB1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of HSP90AB1 mRNA CTD PMID:18544905 NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA1A mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of HSPA1A mRNA CTD PMID:18544905
G Hspa5 heat shock protein family A (Hsp70) member 5 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPA5 mRNA CTD PMID:18544905 NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
JBrowse link
G Hspb1 heat shock protein family B (small) member 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPB1 mRNA CTD PMID:18544905 NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPD1 mRNA CTD PMID:18544905 NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
JBrowse link
G Hspe1 heat shock protein family E (Hsp10) member 1 multiple interactions EXP
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HSPE1 mRNA
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of HSPE1 mRNA
CTD PMID:17917374 PMID:18544905 NCBI chr 9:56,589,912...56,593,000
Ensembl chr 9:56,589,789...56,593,089
JBrowse link
G Hyou1 hypoxia up-regulated 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of HYOU1 mRNA CTD PMID:18544905 NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186
JBrowse link
G Igf2r insulin-like growth factor 2 receptor multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of IGF2R mRNA CTD PMID:18544905 NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
JBrowse link
G Il1a interleukin 1 alpha multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of IL1A mRNA CTD PMID:18544905 NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of IL1B mRNA CTD PMID:18544905 NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
JBrowse link
G Il1rl1 interleukin 1 receptor-like 1 increases expression ISO kojic acid results in increased expression of IL1RL1 mRNA CTD PMID:19000923 NCBI chr 9:42,661,694...42,727,266
Ensembl chr 9:42,697,192...42,727,256
JBrowse link
G Il22ra1 interleukin 22 receptor subunit alpha 1 increases expression ISO kojic acid results in increased expression of IL22RA1 mRNA CTD PMID:16595896 NCBI chr 5:147,961,496...147,986,296
Ensembl chr 5:147,961,349...147,986,296
JBrowse link
G Il6 interleukin 6 decreases expression ISO kojic acid results in decreased expression of IL6 protein CTD PMID:12727023 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
JBrowse link
G Il6st interleukin 6 cytokine family signal transducer decreases expression ISO kojic acid results in decreased expression of IL6ST mRNA CTD PMID:16595896 NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
JBrowse link
G Incenp inner centromere protein increases expression ISO kojic acid results in increased expression of INCENP mRNA CTD PMID:16595896 NCBI chr 1:206,520,655...206,550,575
Ensembl chr 1:206,523,380...206,553,265
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression ISO kojic acid results in increased expression of JUN mRNA CTD PMID:19000923 NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
JBrowse link
G Kars1 lysyl-tRNA synthetase 1 decreases expression ISO kojic acid results in decreased expression of KARS1 mRNA CTD PMID:16595896 NCBI chr19:39,957,846...39,976,886
Ensembl chr19:39,957,846...39,977,632
JBrowse link
G Kcnab3 potassium voltage-gated channel subfamily A regulatory beta subunit 3 decreases expression ISO kojic acid results in decreased expression of KCNAB3 mRNA CTD PMID:16595896 NCBI chr10:54,047,830...54,056,401
Ensembl chr10:54,047,825...54,054,174
JBrowse link
G Kctd17 potassium channel tetramerization domain containing 17 decreases expression ISO kojic acid results in decreased expression of KCTD17 mRNA CTD PMID:16595896 NCBI chr 7:109,979,060...110,009,091
Ensembl chr 7:109,979,060...110,008,927
JBrowse link
G Kdm4d lysine demethylase 4D increases expression ISO kojic acid results in increased expression of KDM4D mRNA CTD PMID:16595896 NCBI chr 8:11,279,756...11,304,920
Ensembl chr 8:11,268,859...11,305,290
JBrowse link
G Klf5 Kruppel-like factor 5 increases expression ISO kojic acid results in increased expression of KLF5 mRNA CTD PMID:16595896 NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
JBrowse link
G Klhl13 kelch-like family member 13 increases expression ISO kojic acid results in increased expression of KLHL13 mRNA CTD PMID:16595896 NCBI chr  X:113,942,309...114,107,355
Ensembl chr  X:113,942,309...114,107,321
JBrowse link
G Klkb1 kallikrein B1 decreases expression ISO kojic acid results in decreased expression of KLKB1 mRNA CTD PMID:16595896 NCBI chr16:46,958,634...46,982,054
Ensembl chr16:46,958,707...46,982,053
JBrowse link
G Krt7 keratin 7 increases expression ISO kojic acid results in increased expression of KRT7 mRNA CTD PMID:16595896 NCBI chr 7:132,528,863...132,545,052
Ensembl chr 7:132,528,895...132,545,052
JBrowse link
G Ktn1 kinectin 1 decreases expression ISO kojic acid results in decreased expression of KTN1 mRNA CTD PMID:16595896 NCBI chr15:20,913,665...21,002,588
Ensembl chr15:20,914,642...21,002,578
JBrowse link
G Larp7 La ribonucleoprotein 7, transcriptional regulator decreases expression ISO kojic acid results in decreased expression of LARP7 mRNA CTD PMID:16595896 NCBI chr 2:215,997,641...216,012,833
Ensembl chr 2:215,997,649...216,012,865
JBrowse link
G Lilrb3 leukocyte immunoglobulin like receptor B3 decreases expression ISO kojic acid results in decreased expression of LILRB5 mRNA CTD PMID:16595896 NCBI chr 1:69,928,948...69,939,461
Ensembl chr 1:69,928,945...69,939,048
JBrowse link
G LOC102555183 zinc finger protein OZF-like decreases expression ISO kojic acid results in decreased expression of ZNF146 mRNA CTD PMID:16595896 NCBI chr 1:85,409,570...85,421,884
Ensembl chr 1:85,409,373...85,436,275
JBrowse link
G LOC103690190 histone H2A type 1-E increases expression ISO kojic acid results in increased expression of H2AC6 mRNA CTD PMID:16595896 NCBI chr17:42,707,863...42,708,420 JBrowse link
G Lrp6 LDL receptor related protein 6 decreases expression ISO kojic acid results in decreased expression of LRP6 mRNA CTD PMID:16595896 NCBI chr 4:167,266,581...167,400,155
Ensembl chr 4:167,270,353...167,400,497
JBrowse link
G Lrrc4 leucine rich repeat containing 4 decreases expression ISO kojic acid results in decreased expression of LRRC4 mRNA CTD PMID:16595896 NCBI chr 4:57,433,518...57,437,114
Ensembl chr 4:57,433,428...57,437,911
JBrowse link
G Lrrc9 leucine rich repeat containing 9 increases expression ISO kojic acid results in increased expression of LRRC9 mRNA CTD PMID:16595896 NCBI chr 6:91,017,739...91,095,847
Ensembl chr 6:91,017,736...91,100,237
JBrowse link
G Maea macrophage erythroblast attacher, E3 ubiquitin ligase increases expression ISO kojic acid results in increased expression of MAEA mRNA CTD PMID:16595896 NCBI chr14:77,357,261...77,390,683
Ensembl chr14:77,357,264...77,390,671
JBrowse link
G Mafk MAF bZIP transcription factor K decreases expression ISO kojic acid results in decreased expression of MAFK mRNA CTD PMID:16595896 NCBI chr12:14,834,628...14,856,414
Ensembl chr12:14,833,984...14,837,048
Ensembl chr12:14,833,984...14,837,048
JBrowse link
G Magec2 MAGE family member C2 increases expression ISO kojic acid results in increased expression of MAGEC2 mRNA CTD PMID:16595896 NCBI chr  X:140,610,610...140,615,484
Ensembl chr  X:140,606,825...140,615,471
JBrowse link
G Maoa monoamine oxidase A multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MAOA mRNA CTD PMID:18544905 NCBI chr  X:6,032,172...6,098,308
Ensembl chr  X:6,030,795...6,099,593
JBrowse link
G Maob monoamine oxidase B multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MAOB mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MAOB mRNA CTD PMID:18544905 NCBI chr  X:5,907,327...6,010,996
Ensembl chr  X:5,907,266...6,011,003
JBrowse link
G Map7d2 MAP7 domain containing 2 decreases expression ISO kojic acid results in decreased expression of MAP7D2 mRNA CTD PMID:16595896 NCBI chr  X:35,372,453...35,488,073
Ensembl chr  X:35,372,700...35,488,091
JBrowse link
G Mapk1 mitogen activated protein kinase 1 decreases phosphorylation ISO kojic acid results in decreased phosphorylation of MAPK1 protein CTD PMID:27586645 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
JBrowse link
G Mapk3 mitogen activated protein kinase 3 decreases phosphorylation ISO kojic acid results in decreased phosphorylation of MAPK3 protein CTD PMID:27586645 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 decreases expression ISO kojic acid results in decreased expression of MAPK8 mRNA CTD PMID:16595896 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
JBrowse link
G Mbnl1 muscleblind-like splicing regulator 1 decreases expression ISO kojic acid results in decreased expression of MBNL1 mRNA CTD PMID:16595896 NCBI chr 2:144,639,819...144,814,395
Ensembl chr 2:144,670,285...144,814,368
JBrowse link
G Mc1r melanocortin 1 receptor decreases expression ISO kojic acid results in decreased expression of MC1R protein CTD PMID:27586645 NCBI chr19:51,452,448...51,455,375 JBrowse link
G Mdfi MyoD family inhibitor decreases expression ISO kojic acid results in decreased expression of MDFI mRNA CTD PMID:16595896 NCBI chr 9:13,156,806...13,175,218
Ensembl chr 9:13,156,866...13,175,217
JBrowse link
G Mdm2 MDM2 proto-oncogene multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MDM2 mRNA CTD PMID:18544905 NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
JBrowse link
G Me3 malic enzyme 3 decreases expression ISO kojic acid results in decreased expression of ME3 mRNA CTD PMID:16595896 NCBI chr 1:143,534,024...143,735,551
Ensembl chr 1:143,534,139...143,733,132
JBrowse link
G Med14 mediator complex subunit 14 increases expression ISO kojic acid results in increased expression of MED14 mRNA CTD PMID:16595896 NCBI chr  X:10,036,749...10,127,910
Ensembl chr  X:10,036,805...10,126,240
JBrowse link
G Mex3b mex-3 RNA binding family member B increases expression ISO kojic acid results in increased expression of MEX3B mRNA CTD PMID:16595896 NCBI chr 1:136,855,130...136,859,365
Ensembl chr 1:136,855,130...136,859,354
JBrowse link
G Mfap4 microfibril associated protein 4 decreases expression ISO kojic acid results in decreased expression of MFAP4 mRNA CTD PMID:16595896 NCBI chr10:46,167,158...46,170,176
Ensembl chr10:46,167,217...46,170,155
JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase multiple interactions EXP [kojic acid co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA; Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA] CTD PMID:18544905 NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MGST1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MGST1 mRNA CTD PMID:18544905 NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
JBrowse link
G Midn midnolin decreases expression ISO kojic acid results in decreased expression of MIDN mRNA CTD PMID:16595896 NCBI chr 7:9,548,100...9,559,605
Ensembl chr 7:9,549,650...9,559,752
JBrowse link
G Mif macrophage migration inhibitory factor multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MIF mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of MIF mRNA CTD PMID:18544905 NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504
JBrowse link
G Mnd1 meiotic nuclear divisions 1 increases expression ISO kojic acid results in increased expression of GAJ mRNA CTD PMID:16595896 NCBI chr 2:169,433,538...169,496,081
Ensembl chr 2:169,433,540...169,496,096
JBrowse link
G Mrpl30 mitochondrial ribosomal protein L30 decreases expression ISO kojic acid results in decreased expression of MRPL30 mRNA CTD PMID:16595896 NCBI chr 9:40,125,352...40,136,189
Ensembl chr 9:40,125,430...40,137,257
JBrowse link
G Mtrex Mtr4 exosome RNA helicase decreases expression ISO kojic acid results in decreased expression of MTREX mRNA CTD PMID:16595896 NCBI chr 2:44,500,326...44,560,624
Ensembl chr 2:44,461,444...44,560,627
JBrowse link
G Mvp major vault protein multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of MVP mRNA CTD PMID:18544905 NCBI chr 1:181,594,734...181,622,336
Ensembl chr 1:181,594,734...181,622,380
JBrowse link
G Naa25 N(alpha)-acetyltransferase 25, NatB auxiliary subunit increases expression ISO kojic acid results in increased expression of NAA25 mRNA CTD PMID:16595896 NCBI chr12:35,098,075...35,150,544
Ensembl chr12:35,098,075...35,150,467
JBrowse link
G Ncald neurocalcin delta decreases expression ISO kojic acid results in decreased expression of NCALD mRNA CTD PMID:16595896 NCBI chr 7:68,532,671...68,964,740
Ensembl chr 7:68,534,421...68,964,496
JBrowse link
G Ndufa1 NADH:ubiquinone oxidoreductase subunit A1 increases expression ISO kojic acid results in increased expression of NDUFA1 mRNA CTD PMID:16595896 NCBI chr  X:116,424,223...116,427,875
Ensembl chr  X:116,424,223...116,428,633
JBrowse link
G Nectin4 nectin cell adhesion molecule 4 increases expression ISO kojic acid results in increased expression of NECTIN4 mRNA CTD PMID:16595896 NCBI chr13:83,802,589...83,821,711
Ensembl chr13:83,803,184...83,821,709
JBrowse link
G Nfil3 nuclear factor, interleukin 3 regulated increases expression ISO kojic acid results in increased expression of NFIL3 mRNA CTD PMID:16595896 NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NFKBIA mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of NFKBIA mRNA CTD PMID:18544905 NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
JBrowse link
G Nfkbie NFKB inhibitor epsilon increases expression ISO kojic acid results in increased expression of NFKBIE mRNA CTD PMID:16595896 NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
JBrowse link
G Nkx6-1 NK6 homeobox 1 decreases expression ISO kojic acid results in decreased expression of NKX6-1 mRNA CTD PMID:16595896 NCBI chr14:7,969,756...7,976,689
Ensembl chr14:7,969,756...7,976,681
JBrowse link
G Nlgn2 neuroligin 2 decreases expression ISO kojic acid results in decreased expression of NLGN2 mRNA CTD PMID:16595896 NCBI chr10:54,544,588...54,557,854
Ensembl chr10:54,544,588...54,558,434
JBrowse link
G Noc3l NOC3-like DNA replication regulator decreases expression ISO kojic acid results in decreased expression of NOC3L mRNA CTD PMID:16595896 NCBI chr 1:236,556,037...236,585,372
Ensembl chr 1:236,556,789...236,585,318
JBrowse link
G Nol11 nucleolar protein 11 decreases expression ISO kojic acid results in decreased expression of NOL11 mRNA CTD PMID:16595896 NCBI chr10:92,119,000...92,141,688
Ensembl chr10:92,121,833...92,141,677
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NR1I2 mRNA CTD PMID:18544905 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of NR1I3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of NR1I3 mRNA CTD PMID:18544905 NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
JBrowse link
G Odad2 outer dynein arm docking complex subunit 2 increases expression ISO kojic acid results in increased expression of ODAD2 mRNA CTD PMID:16595896 NCBI chr17:55,216,877...55,409,872
Ensembl chr17:55,218,991...55,409,399
JBrowse link
G Olfml1 olfactomedin-like 1 decreases expression ISO kojic acid results in decreased expression of OLFML1 mRNA CTD PMID:16595896 NCBI chr 1:161,478,129...161,502,541
Ensembl chr 1:161,478,242...161,502,537
JBrowse link
G Olr130 olfactory receptor 130 decreases expression ISO kojic acid results in decreased expression of OR51B4 mRNA CTD PMID:16595896 NCBI chr 1:158,317,228...158,318,151
Ensembl chr 1:158,317,228...158,318,151
JBrowse link
G Osbp2 oxysterol binding protein 2 decreases expression ISO kojic acid results in decreased expression of OSBP2 mRNA CTD PMID:16595896 NCBI chr14:78,585,088...78,746,785
Ensembl chr14:78,585,089...78,746,786
JBrowse link
G Ostm1 osteoclastogenesis associated transmembrane protein 1 decreases expression ISO kojic acid results in decreased expression of OSTM1 mRNA CTD PMID:16595896 NCBI chr20:46,071,657...46,187,049
Ensembl chr20:46,153,075...46,187,023
JBrowse link
G Otx1 orthodenticle homeobox 1 increases expression ISO kojic acid results in increased expression of OTX1 mRNA CTD PMID:16595896 NCBI chr14:96,082,151...96,089,161
Ensembl chr14:96,082,151...96,089,086
JBrowse link
G Pabir1 PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1 increases expression ISO kojic acid results in increased expression of PABIR1 mRNA CTD PMID:16595896 NCBI chr 1:222,114,988...222,116,294
Ensembl chr 1:222,112,591...222,116,396
JBrowse link
G Pagr1 Paxip1-associated glutamate-rich protein 1 increases expression ISO kojic acid results in increased expression of PAGR1 mRNA CTD PMID:16595896 NCBI chr 1:181,622,708...181,624,996 JBrowse link
G Pah phenylalanine hydroxylase decreases expression ISO kojic acid results in decreased expression of PAH mRNA CTD PMID:16595896 NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
JBrowse link
G Parg poly (ADP-ribose) glycohydrolase increases expression ISO kojic acid results in increased expression of PARG mRNA CTD PMID:16595896 NCBI chr16:7,436,429...7,544,276
Ensembl chr16:7,436,476...7,544,273
JBrowse link
G Pbk PDZ binding kinase decreases expression ISO kojic acid results in decreased expression of PBK mRNA CTD PMID:16595896 NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions ISO
EXP
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of PCNA protein
[Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of PCNA protein
CTD PMID:17917374 PMID:18544905 NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
JBrowse link
G Pcnx3 pecanex 3 decreases expression ISO kojic acid results in decreased expression of PCNX3 mRNA CTD PMID:16595896 NCBI chr 1:202,951,322...202,974,167
Ensembl chr 1:202,951,322...202,976,561
JBrowse link
G Pcsk4 proprotein convertase subtilisin/kexin type 4 decreases expression ISO kojic acid results in decreased expression of PCSK4 mRNA CTD PMID:16595896 NCBI chr 7:9,381,366...9,389,589
Ensembl chr 7:9,381,361...9,389,585
JBrowse link
G Pdcl phosducin-like increases expression ISO kojic acid results in increased expression of PDCL mRNA CTD PMID:16595896 NCBI chr 3:21,110,165...21,119,763
Ensembl chr 3:21,110,167...21,119,715
JBrowse link
G Pdha1 pyruvate dehydrogenase E1 subunit alpha 1 increases expression ISO kojic acid results in increased expression of PDHA1 mRNA CTD PMID:16595896 NCBI chr  X:34,700,481...34,714,309
Ensembl chr  X:34,700,409...34,714,311
JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PDIA3 mRNA CTD PMID:18544905 NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
JBrowse link
G Pdlim2 PDZ and LIM domain 2 increases expression ISO kojic acid results in increased expression of PDLIM2 mRNA CTD PMID:16595896 NCBI chr15:45,235,421...45,250,187
Ensembl chr15:45,237,477...45,249,242
JBrowse link
G Perm1 PPARGC1 and ESRR induced regulator, muscle 1 decreases expression ISO kojic acid results in decreased expression of PERM1 mRNA CTD PMID:16595896 NCBI chr 5:166,800,030...166,805,323
Ensembl chr 5:166,800,030...166,805,323
JBrowse link
G Pex5l peroxisomal biogenesis factor 5-like decreases expression ISO kojic acid results in decreased expression of PEX5L mRNA CTD PMID:16595896 NCBI chr 2:115,694,868...115,908,338
Ensembl chr 2:115,700,972...115,913,628
JBrowse link
G Pgm2 phosphoglucomutase 2 increases expression ISO kojic acid results in increased expression of PGM2 mRNA CTD PMID:16595896 NCBI chr14:44,166,314...44,199,823
Ensembl chr14:44,164,425...44,199,967
JBrowse link
G Pigq phosphatidylinositol glycan anchor biosynthesis, class Q decreases expression ISO kojic acid results in decreased expression of PIGQ mRNA CTD PMID:16595896 NCBI chr10:14,942,571...14,958,584
Ensembl chr10:14,942,577...14,958,584
JBrowse link
G Pitpnb phosphatidylinositol transfer protein, beta increases expression ISO kojic acid results in increased expression of PITPNB mRNA CTD PMID:16595896 NCBI chr12:45,249,308...45,298,388
Ensembl chr12:45,249,333...45,298,314
JBrowse link
G Plagl1 PLAG1 like zinc finger 1 increases expression ISO kojic acid results in increased expression of PLAGL1 mRNA CTD PMID:16595896 NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228
JBrowse link
G Poglut2 protein O-glucosyltransferase 2 increases expression ISO kojic acid results in increased expression of POGLUT2 mRNA CTD PMID:16595896 NCBI chr 9:46,256,388...46,268,714
Ensembl chr 9:46,256,390...46,268,532
JBrowse link
G Pon3 paraoxonase 3 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PON3 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of PON3 mRNA CTD PMID:18544905 NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
JBrowse link
G Por cytochrome p450 oxidoreductase multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of POR mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of POR mRNA CTD PMID:18544905 NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
JBrowse link
G Pou2f3 POU class 2 homeobox 3 decreases expression ISO kojic acid results in decreased expression of POU2F3 mRNA CTD PMID:16595896 NCBI chr 8:43,495,408...43,577,795
Ensembl chr 8:43,495,527...43,577,795
JBrowse link
G Ppp4r1 protein phosphatase 4, regulatory subunit 1 increases expression ISO kojic acid results in increased expression of PPP4R1 mRNA CTD PMID:16595896 NCBI chr 9:105,391,271...105,450,626
Ensembl chr 9:105,391,412...105,450,633
JBrowse link
G Prdx1 peroxiredoxin 1 multiple interactions EXP [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PRDX1 mRNA CTD PMID:18544905 NCBI chr 5:130,147,276...130,162,850
Ensembl chr 5:130,147,204...130,162,856
JBrowse link
G Prdx2 peroxiredoxin 2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of PRDX2 mRNA CTD PMID:18544905 NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
JBrowse link
G Prg2 proteoglycan 2 decreases expression ISO kojic acid results in decreased expression of PRG2 mRNA CTD PMID:16595896 NCBI chr 3:70,062,535...70,066,102
Ensembl chr 3:70,062,535...70,066,101
JBrowse link
G Prickle3 prickle planar cell polarity protein 3 decreases expression ISO kojic acid results in decreased expression of PRICKLE3 mRNA CTD PMID:16595896 NCBI chr  X:14,837,647...14,849,305
Ensembl chr  X:14,837,650...14,848,218
JBrowse link
G Prim1 DNA primase subunit 1 decreases expression ISO kojic acid results in decreased expression of PRIM1 mRNA CTD PMID:16595896 NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526
JBrowse link
G Prmt2 protein arginine methyltransferase 2 decreases expression ISO kojic acid results in decreased expression of PRMT2 mRNA CTD PMID:16595896 NCBI chr20:12,394,748...12,420,643
Ensembl chr20:12,394,798...12,420,643
JBrowse link
G Prpf40a pre-mRNA processing factor 40 homolog A decreases expression ISO kojic acid results in decreased expression of PRPF40A mRNA CTD PMID:16595896 NCBI chr 3:37,625,585...37,689,859
Ensembl chr 3:37,627,690...37,690,886
JBrowse link
G Prps2 phosphoribosyl pyrophosphate synthetase 2 increases expression ISO kojic acid results in increased expression of PRPS2 mRNA CTD PMID:16595896 NCBI chr  X:26,975,915...27,013,184
Ensembl chr  X:26,976,061...27,013,181
JBrowse link
G Prr18 proline rich 18 decreases expression ISO kojic acid results in decreased expression of PRR18 mRNA CTD PMID:16595896 NCBI chr 1:52,400,215...52,404,492
Ensembl chr 1:52,400,215...52,404,309
JBrowse link
G Prrc2c proline-rich coiled-coil 2C increases expression ISO kojic acid results in increased expression of PRRC2C mRNA CTD PMID:16595896 NCBI chr13:75,003,995...75,073,701 JBrowse link
G Prrx1 paired related homeobox 1 decreases expression ISO kojic acid results in decreased expression of PRRX1 mRNA CTD PMID:16595896 NCBI chr13:75,600,777...75,671,896
Ensembl chr13:75,601,706...75,670,866
JBrowse link
G Psmc6 proteasome 26S subunit, ATPase 6 decreases expression ISO kojic acid results in decreased expression of PSMC6 mRNA CTD PMID:16595896 NCBI chr15:18,542,585...18,564,057
Ensembl chr15:18,542,563...18,564,055
JBrowse link
G Psmd3 proteasome 26S subunit, non-ATPase 3 decreases expression ISO kojic acid results in decreased expression of PSMD3 mRNA CTD PMID:16595896 NCBI chr10:83,643,473...83,655,620
Ensembl chr10:83,643,647...83,655,618
JBrowse link
G Pus7l pseudouridine synthase 7 like decreases expression ISO kojic acid results in decreased expression of PUS7L mRNA CTD PMID:16595896 NCBI chr 7:125,659,507...125,706,582
Ensembl chr 7:125,659,507...125,682,333
JBrowse link
G Rab3gap1 RAB3 GTPase activating protein catalytic subunit 1 increases expression ISO kojic acid results in increased expression of RAB3GAP1 mRNA CTD PMID:16595896 NCBI chr13:39,355,698...39,429,154
Ensembl chr13:39,352,247...39,429,169
JBrowse link
G Rab6b RAB6B, member RAS oncogene family decreases expression ISO kojic acid results in decreased expression of RAB6B mRNA CTD PMID:16595896 NCBI chr 8:103,695,328...103,764,023
Ensembl chr 8:103,695,631...103,805,732
JBrowse link
G Rad1 RAD1 checkpoint DNA exonuclease increases expression ISO kojic acid results in increased expression of RAD1 mRNA CTD PMID:16595896 NCBI chr 2:59,461,597...59,469,707
Ensembl chr 2:59,461,607...59,469,689
JBrowse link
G Rad23a RAD23 homolog A, nucleotide excision repair protein multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RAD23A mRNA CTD PMID:18544905 NCBI chr19:23,313,563...23,320,702
Ensembl chr19:23,314,797...23,320,695
JBrowse link
G Rad50 RAD50 double strand break repair protein multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of RAD50 mRNA CTD PMID:17917374 NCBI chr10:37,809,353...37,861,309
Ensembl chr10:37,808,726...37,861,396
JBrowse link
G Rara retinoic acid receptor, alpha multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARA mRNA CTD PMID:18544905 NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
JBrowse link
G Rarb retinoic acid receptor, beta multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of RARB mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of RARB mRNA CTD PMID:18544905 NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
JBrowse link
G Rasd1 ras related dexamethasone induced 1 increases expression ISO kojic acid results in increased expression of RASD1 mRNA CTD PMID:16595896 NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
JBrowse link
G Rasgef1b RasGEF domain family, member 1B decreases expression ISO kojic acid results in decreased expression of RASGEF1B mRNA CTD PMID:16595896 NCBI chr14:9,859,512...10,380,044
Ensembl chr14:9,860,247...10,379,741
JBrowse link
G Rassf3 Ras association domain family member 3 increases expression ISO kojic acid results in increased expression of RASSF3 mRNA CTD PMID:16595896 NCBI chr 7:56,935,894...57,000,591
Ensembl chr 7:56,935,973...57,000,553
JBrowse link
G Rb1cc1 RB1-inducible coiled-coil 1 decreases expression ISO kojic acid results in decreased expression of RB1CC1 mRNA CTD PMID:16595896 NCBI chr 5:13,161,648...13,225,560
Ensembl chr 5:13,161,648...13,225,560
JBrowse link
G Rbm38 RNA binding motif protein 38 decreases expression ISO kojic acid results in decreased expression of RBM38 mRNA CTD PMID:16595896 NCBI chr 3:161,801,550...161,814,381
Ensembl chr 3:161,801,577...161,814,381
JBrowse link
G Recql RecQ like helicase decreases expression ISO kojic acid results in decreased expression of RECQL mRNA CTD PMID:16595896 NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945
JBrowse link
G RGD1311164 similar to DNA segment, Chr 6, Wayne State University 163, expressed decreases expression ISO kojic acid results in decreased expression of C12ORF4 mRNA CTD PMID:16595896 NCBI chr 4:159,772,693...159,809,322
Ensembl chr 4:159,772,786...159,806,382
JBrowse link
G RGD1560146 similar to hypothetical protein MGC34837 decreases expression ISO kojic acid results in decreased expression of C1ORF87 mRNA CTD PMID:16595896 NCBI chr 5:111,342,381...111,411,576
Ensembl chr 5:111,342,387...111,411,590
JBrowse link
G RGD1562218 similar to RIKEN cDNA 0610039J04 decreases expression ISO kojic acid results in decreased expression of C1ORF131 mRNA CTD PMID:16595896 NCBI chr19:52,807,932...52,822,259
Ensembl chr19:52,807,934...52,822,267
JBrowse link
G Rims2 regulating synaptic membrane exocytosis 2 decreases expression ISO kojic acid results in decreased expression of RIMS2 mRNA CTD PMID:16595896 NCBI chr 7:70,248,104...70,759,134
Ensembl chr 7:70,243,872...70,757,491
JBrowse link
G Rsbn1 round spermatid basic protein 1 decreases expression ISO kojic acid results in decreased expression of RSBN1 mRNA CTD PMID:16595896 NCBI chr 2:191,416,631...191,470,711
Ensembl chr 2:191,416,631...191,470,711
JBrowse link
G Saa4 serum amyloid A4 decreases expression ISO kojic acid results in decreased expression of SAA4 mRNA CTD PMID:16595896 NCBI chr 1:97,247,580...97,251,882 JBrowse link
G Scarb1 scavenger receptor class B, member 1 increases expression ISO kojic acid results in increased expression of SCARB1 mRNA CTD PMID:19000923 NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
JBrowse link
G Scn10a sodium voltage-gated channel alpha subunit 10 decreases expression ISO kojic acid results in decreased expression of SCN10A mRNA CTD PMID:16595896 NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
JBrowse link
G Scp2 sterol carrier protein 2 decreases expression ISO kojic acid results in decreased expression of SCP2 mRNA CTD PMID:16595896 NCBI chr 5:122,806,949...122,881,259
Ensembl chr 5:122,776,549...122,881,287
JBrowse link
G Sdc4 syndecan 4 decreases expression ISO kojic acid results in decreased expression of SDC4 mRNA CTD PMID:16595896 NCBI chr 3:153,154,888...153,173,576
Ensembl chr 3:153,154,896...153,173,580
JBrowse link
G Sec24b SEC24 homolog B, COPII coat complex component increases expression ISO kojic acid results in increased expression of SEC24B mRNA CTD PMID:16595896 NCBI chr 2:218,562,670...218,632,753
Ensembl chr 2:218,562,676...218,632,699
JBrowse link
G Sec62 SEC62 homolog, preprotein translocation factor decreases expression ISO kojic acid results in decreased expression of SEC62 mRNA CTD PMID:16595896 NCBI chr 2:112,570,810...112,607,576
Ensembl chr 2:112,570,819...112,601,814
JBrowse link
G Sectm1b secreted and transmembrane 1B decreases expression ISO kojic acid results in decreased expression of SECTM1 mRNA CTD PMID:16595896 NCBI chr10:106,325,202...106,333,769
Ensembl chr10:106,325,203...106,333,769
JBrowse link
G Septin7 septin 7 decreases expression ISO kojic acid results in decreased expression of SEPTIN7 mRNA CTD PMID:16595896 NCBI chr 8:23,719,448...23,783,247
Ensembl chr 8:23,716,030...23,783,243
JBrowse link
G Serpina5 serpin family A member 5 decreases expression ISO kojic acid results in decreased expression of SERPINA5 mRNA CTD PMID:16595896 NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407
JBrowse link
G Shcbp1 SHC binding and spindle associated 1 increases expression ISO kojic acid results in increased expression of SHCBP1 mRNA CTD PMID:16595896 NCBI chr16:84,672,276...84,703,839
Ensembl chr16:84,672,321...84,703,844
JBrowse link
G Sin3b SIN3 transcription regulator family member B decreases expression ISO kojic acid results in decreased expression of SIN3B mRNA CTD PMID:16595896 NCBI chr16:17,123,277...17,160,070
Ensembl chr16:17,123,434...17,159,978
JBrowse link
G Slc17a2 solute carrier family 17, member 2 decreases expression ISO kojic acid results in decreased expression of SLC17A2 mRNA CTD PMID:16595896 NCBI chr17:41,318,312...41,339,012
Ensembl chr17:41,319,701...41,336,325
JBrowse link
G Slc25a2 solute carrier family 25 member 2 decreases expression ISO kojic acid results in decreased expression of SLC25A2 mRNA CTD PMID:16595896 NCBI chr18:29,452,943...29,457,906
Ensembl chr18:29,453,582...29,460,383
JBrowse link
G Slc38a4 solute carrier family 38, member 4 decreases expression ISO kojic acid results in decreased expression of SLC38A4 mRNA CTD PMID:16595896 NCBI chr 7:128,142,866...128,203,000
Ensembl chr 7:128,144,807...128,202,995
JBrowse link
G Smc6 structural maintenance of chromosomes 6 decreases expression ISO kojic acid results in decreased expression of SMC6 mRNA CTD PMID:16595896 NCBI chr 6:33,978,730...34,033,201
Ensembl chr 6:33,978,716...34,031,746
JBrowse link
G Smim8 small integral membrane protein 8 decreases expression ISO kojic acid results in decreased expression of SMIM8 mRNA CTD PMID:16595896 NCBI chr 5:49,336,617...49,345,625
Ensembl chr 5:49,336,617...49,345,441
JBrowse link
G Snx10 sorting nexin 10 decreases expression ISO kojic acid results in decreased expression of SNX10 mRNA CTD PMID:16595896 NCBI chr 4:80,612,648...80,677,005
Ensembl chr 4:80,612,669...80,676,996
JBrowse link
G Soat2 sterol O-acyltransferase 2 increases expression ISO kojic acid results in increased expression of SOAT2 mRNA CTD PMID:16595896 NCBI chr 7:133,281,818...133,294,915
Ensembl chr 7:133,281,818...133,294,915
JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SOD1 mRNA CTD PMID:18544905 NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SOD2 mRNA CTD PMID:18544905 NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
JBrowse link
G Spata25 spermatogenesis associated 25 decreases expression ISO kojic acid results in decreased expression of SPATA25 mRNA CTD PMID:16595896 NCBI chr 3:153,562,479...153,566,508
Ensembl chr 3:153,562,528...153,564,480
JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression ISO kojic acid results in increased expression of SPP1 mRNA CTD PMID:16595896 NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
JBrowse link
G Sptlc1 serine palmitoyltransferase, long chain base subunit 1 increases expression ISO kojic acid results in increased expression of SPTLC1 mRNA CTD PMID:16595896 NCBI chr17:11,877,249...11,916,295
Ensembl chr17:11,877,249...11,916,295
JBrowse link
G Srsf2 serine and arginine rich splicing factor 2 increases expression ISO kojic acid results in increased expression of SRSF2 mRNA CTD PMID:16595896 NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
JBrowse link
G Ssx1 SSX family member 1 increases expression ISO kojic acid results in increased expression of SSX1 mRNA CTD PMID:16595896 NCBI chr  X:13,931,433...13,939,732
Ensembl chr  X:13,931,470...13,939,720
JBrowse link
G St13 ST13, Hsp70 interacting protein multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of ST13 mRNA CTD PMID:18544905 NCBI chr 7:112,891,007...112,925,727 JBrowse link
G St18 ST18 C2H2C-type zinc finger transcription factor decreases expression ISO kojic acid results in decreased expression of ST18 mRNA CTD PMID:16595896 NCBI chr 5:12,582,493...12,914,221
Ensembl chr 5:12,584,110...12,671,790
JBrowse link
G Stard8 StAR-related lipid transfer domain containing 8 decreases expression ISO kojic acid results in decreased expression of STARD8 mRNA CTD PMID:16595896 NCBI chr  X:64,079,079...64,196,052
Ensembl chr  X:64,124,574...64,196,052
JBrowse link
G Stx6 syntaxin 6 increases expression ISO kojic acid results in increased expression of STX6 mRNA CTD PMID:16595896 NCBI chr13:67,332,329...67,378,580
Ensembl chr13:67,332,314...67,378,576
JBrowse link
G Sult1a1 sulfotransferase family 1A member 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of SULT1A1 mRNA CTD PMID:18544905 NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
JBrowse link
G Sult1b1 sulfotransferase family 1B member 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1B1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in increased expression of SULT1B1 mRNA CTD PMID:18544905 NCBI chr14:20,492,763...20,505,491
Ensembl chr14:20,492,708...20,505,483
JBrowse link
G Sult1c2a sulfotransferase family, cytosolic, 1C, member 2a multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1C2 mRNA CTD PMID:18544905 NCBI chr 9:6,873,697...6,904,736
Ensembl chr 9:6,874,249...6,904,734
JBrowse link
G Sult1c3 sulfotransferase family 1C member 3 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1C1 mRNA CTD PMID:18544905 NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,221,578...7,267,030
JBrowse link
G Sult1e1 sulfotransferase family 1E member 1 multiple interactions EXP
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT1E1 mRNA
[Diethylnitrosamine co-treated with kojic acid] results in decreased expression of SULT1E1 mRNA
CTD PMID:17917374 PMID:18544905 NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
JBrowse link
G Sult4a1 sulfotransferase family 4A, member 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of SULT4A1 mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of SULT4A1 mRNA CTD PMID:18544905 NCBI chr 7:115,216,066...115,240,156
Ensembl chr 7:115,216,066...115,240,085
JBrowse link
G Suz12 SUZ12 polycomb repressive complex 2 subunit decreases expression ISO kojic acid results in decreased expression of SUZ12 mRNA CTD PMID:16595896 NCBI chr10:64,967,035...65,012,916
Ensembl chr10:64,966,967...65,012,738
JBrowse link
G Swap70 switching B-cell complex subunit SWAP70 increases expression ISO kojic acid results in increased expression of SWAP70 mRNA CTD PMID:16595896 NCBI chr 1:164,267,588...164,328,796
Ensembl chr 1:164,267,609...164,328,794
JBrowse link
G Syf2 SYF2 pre-mRNA-splicing factor decreases expression ISO kojic acid results in decreased expression of SYF2 mRNA CTD PMID:16595896 NCBI chr 5:147,156,492...147,164,416
Ensembl chr 5:147,156,480...147,164,414
JBrowse link
G Sympk symplekin scaffold protein decreases expression ISO kojic acid results in decreased expression of SYMPK mRNA CTD PMID:16595896 NCBI chr 1:78,672,326...78,700,684
Ensembl chr 1:78,672,378...78,700,684
JBrowse link
G Syncrip synaptotagmin binding, cytoplasmic RNA interacting protein increases expression ISO kojic acid results in increased expression of SYNCRIP mRNA CTD PMID:16595896 NCBI chr 8:89,402,487...89,435,517
Ensembl chr 8:89,402,866...89,435,515
JBrowse link
G Taf15 TATA-box binding protein associated factor 15 decreases expression ISO kojic acid results in decreased expression of TAF15 mRNA CTD PMID:16595896 NCBI chr10:68,272,900...68,304,951
Ensembl chr10:68,272,969...68,304,949
JBrowse link
G Tal1 TAL bHLH transcription factor 1, erythroid differentiation factor decreases expression ISO kojic acid results in decreased expression of TAL1 mRNA CTD PMID:16595896 NCBI chr 5:128,586,776...128,600,976
Ensembl chr 5:128,587,701...128,600,976
JBrowse link
G Tbxas1 thromboxane A synthase 1 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TBXAS1 mRNA CTD PMID:18544905 NCBI chr 4:67,664,963...67,837,096
Ensembl chr 4:67,665,007...67,837,096
JBrowse link
G Tcf21 transcription factor 21 decreases expression ISO kojic acid results in decreased expression of TCF21 mRNA CTD PMID:16595896 NCBI chr 1:22,701,353...22,704,212
Ensembl chr 1:22,701,353...22,704,202
JBrowse link
G Tent4b terminal nucleotidyltransferase 4B decreases expression ISO kojic acid results in decreased expression of TENT4B mRNA CTD PMID:16595896 NCBI chr19:18,807,616...18,868,969
Ensembl chr19:18,807,525...18,869,537
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TGFB1 mRNA CTD PMID:18544905 NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
JBrowse link
G Thrb thyroid hormone receptor beta decreases expression ISO kojic acid results in decreased expression of THRB mRNA CTD PMID:16595896 NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
JBrowse link
G Tie1 tyrosine kinase with immunoglobulin-like and EGF-like domains 1 decreases expression ISO kojic acid results in decreased expression of TIE mRNA CTD PMID:16595896 NCBI chr 5:132,000,013...132,019,658
Ensembl chr 5:132,000,015...132,019,592
JBrowse link
G Tirap TIR domain containing adaptor protein decreases expression ISO kojic acid results in decreased expression of TIRAP mRNA CTD PMID:16595896 NCBI chr 8:33,531,724...33,548,508
Ensembl chr 8:33,531,725...33,547,432
JBrowse link
G Tmco5a transmembrane and coiled-coil domains 5A increases expression ISO kojic acid results in increased expression of TMCO5 mRNA CTD PMID:16595896 NCBI chr 3:103,732,936...103,746,242
Ensembl chr 3:103,732,945...103,746,249
JBrowse link
G Tmem217 transmembrane protein 217 increases expression ISO kojic acid results in increased expression of TMEM217 mRNA CTD PMID:16595896 NCBI chr20:7,584,177...7,619,023
Ensembl chr20:7,592,627...7,619,111
Ensembl chr20:7,592,627...7,619,111
JBrowse link
G Tmem59l transmembrane protein 59-like decreases expression ISO kojic acid results in decreased expression of TMEM59L mRNA CTD PMID:16595896 NCBI chr16:18,941,370...18,945,381
Ensembl chr16:18,941,567...18,945,381
JBrowse link
G Tmx1 thioredoxin-related transmembrane protein 1 decreases expression ISO kojic acid results in decreased expression of TMX1 mRNA CTD PMID:16595896 NCBI chr 6:88,960,724...88,971,301
Ensembl chr 6:88,960,695...88,971,301
JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNF mRNA CTD PMID:18544905 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
JBrowse link
G Tnfaip8l1 TNF alpha induced protein 8 like 1 decreases expression ISO kojic acid results in decreased expression of TNFAIP8L1 mRNA CTD PMID:16595896 NCBI chr 9:988,587...999,342 JBrowse link
G Tnfsf10 TNF superfamily member 10 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TNFSF10 mRNA CTD PMID:18544905 NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
JBrowse link
G Tor4a torsin family 4, member A decreases expression ISO kojic acid results in decreased expression of TOR4A mRNA CTD PMID:16595896 NCBI chr 3:8,004,292...8,007,979
Ensembl chr 3:8,002,023...8,008,042
JBrowse link
G Tp53 tumor protein p53 multiple interactions EXP
ISO
[Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TP53 mRNA
[Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of TRP53 mRNA
CTD PMID:17917374 PMID:18544905 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
JBrowse link
G Tp53bp2 tumor protein p53 binding protein, 2 increases expression ISO kojic acid results in increased expression of TP53BP2 mRNA CTD PMID:16595896 NCBI chr13:94,088,769...94,145,436
Ensembl chr13:94,088,709...94,145,432
JBrowse link
G Tpcn1 two pore segment channel 1 increases expression ISO kojic acid results in increased expression of TPCN1 mRNA CTD PMID:16595896 NCBI chr12:35,972,813...36,029,632
Ensembl chr12:35,972,846...36,029,626
JBrowse link
G Tpst2 tyrosylprotein sulfotransferase 2 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TPST2 mRNA CTD PMID:17917374 NCBI chr12:44,321,875...44,363,892
Ensembl chr12:44,321,875...44,362,329
JBrowse link
G Tradd TNFRSF1A-associated via death domain multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of TRADD mRNA; [Diethylnitrosamine co-treated with kojic acid] results in decreased expression of TRADD mRNA CTD PMID:18544905 NCBI chr19:33,136,148...33,142,714
Ensembl chr19:33,136,138...33,142,638
JBrowse link
G Tram1 translocation associated membrane protein 1 decreases expression ISO kojic acid results in decreased expression of TRAM1 mRNA CTD PMID:16595896 NCBI chr 5:5,642,579...5,667,666
Ensembl chr 5:5,642,546...5,686,971
JBrowse link
G Tram2 translocation associated membrane protein 2 decreases expression ISO kojic acid results in decreased expression of TRAM2 mRNA CTD PMID:16595896 NCBI chr 9:23,419,204...23,498,745
Ensembl chr 9:23,424,232...23,498,689
JBrowse link
G Trem1 triggering receptor expressed on myeloid cells 1 decreases expression ISO kojic acid results in decreased expression of TREM1 mRNA CTD PMID:16595896 NCBI chr 9:12,763,819...12,779,285
Ensembl chr 9:12,763,819...12,779,203
JBrowse link
G Trmt10c tRNA methyltransferase 10C, mitochondrial RNase P subunit decreases expression ISO kojic acid results in decreased expression of TRMT10C mRNA CTD PMID:16595896 NCBI chr11:44,584,388...44,589,466
Ensembl chr11:44,584,113...44,589,568
JBrowse link
G Tspan8 tetraspanin 8 increases expression ISO kojic acid results in increased expression of TSPAN8 mRNA CTD PMID:16595896 NCBI chr 7:51,444,946...51,479,360
Ensembl chr 7:51,445,074...51,479,356
JBrowse link
G Ttc9 tetratricopeptide repeat domain 9 increases expression ISO kojic acid results in increased expression of TTC9 mRNA CTD PMID:16595896 NCBI chr 6:101,333,274...101,368,110
Ensembl chr 6:101,333,141...101,368,110
JBrowse link
G Ttk Ttk protein kinase decreases expression ISO kojic acid results in decreased expression of TTK mRNA CTD PMID:16595896 NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
JBrowse link
G Tulp3 TUB like protein 3 decreases expression ISO kojic acid results in decreased expression of TULP3 mRNA CTD PMID:16595896 NCBI chr 4:161,590,478...161,632,514
Ensembl chr 4:161,590,479...161,632,149
JBrowse link
G Twf1 twinfilin actin-binding protein 1 decreases expression ISO kojic acid results in decreased expression of TWF1 mRNA CTD PMID:16595896 NCBI chr 7:125,715,938...125,727,834
Ensembl chr 7:125,716,015...125,727,894
JBrowse link
G Tyr tyrosinase decreases activity ISO kojic acid results in decreased activity of TYR protein CTD PMID:27586645 NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
JBrowse link
G Tyrp1 tyrosinase-related protein 1 decreases expression ISO kojic acid results in decreased expression of TYRP1 protein CTD PMID:27586645 NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
JBrowse link
G Ube2d4 ubiquitin-conjugating enzyme E2D 4 (putative) decreases expression ISO kojic acid results in decreased expression of UBE2D4 mRNA CTD PMID:16595896 NCBI chr14:1,915,999...1,917,473
Ensembl chr14:1,916,845...1,917,416
JBrowse link
G Ube2e1 ubiquitin-conjugating enzyme E2E 1 decreases expression ISO kojic acid results in decreased expression of UBE2E1 mRNA CTD PMID:16595896 NCBI chr15:7,439,502...7,493,410
Ensembl chr15:7,439,759...7,493,400
JBrowse link
G Ube2m ubiquitin-conjugating enzyme E2M decreases expression ISO kojic acid results in decreased expression of UBE2M mRNA CTD PMID:16595896 NCBI chr 1:73,662,576...73,666,113
Ensembl chr 1:73,662,576...73,666,026
JBrowse link
G Ubr7 ubiquitin protein ligase E3 component n-recognin 7 increases expression ISO kojic acid results in increased expression of UBR7 mRNA CTD PMID:16595896 NCBI chr 6:121,898,613...121,918,480
Ensembl chr 6:121,898,623...121,918,477
JBrowse link
G Ufd1 ubiquitin recognition factor in ER associated degradation 1 increases expression ISO kojic acid results in increased expression of UFD1 mRNA CTD PMID:16595896 NCBI chr11:82,161,618...82,185,107
Ensembl chr11:82,161,619...82,185,087
JBrowse link
G Ugt1a2 UDP glucuronosyltransferase 1 family, polypeptide A2 multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of UGT1A2 mRNA CTD PMID:17917374 NCBI chr 9:88,791,216...88,808,465 JBrowse link
G Ugt1a6 UDP glucuronosyltransferase family 1 member A6 multiple interactions EXP [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of UGT1A6 mRNA CTD PMID:18544905 NCBI chr 9:88,747,229...88,808,465 JBrowse link
G Unc5c unc-5 netrin receptor C decreases expression ISO kojic acid results in decreased expression of UNC5C mRNA CTD PMID:16595896 NCBI chr 2:230,180,353...230,535,219
Ensembl chr 2:230,180,951...230,535,217
JBrowse link
G Ung uracil-DNA glycosylase multiple interactions ISO [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of UNG mRNA CTD PMID:17917374 NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206
JBrowse link
G Usp1 ubiquitin specific peptidase 1 decreases expression ISO kojic acid results in decreased expression of USP1 mRNA CTD PMID:16595896 NCBI chr 5:113,587,564...113,598,934
Ensembl chr 5:113,587,564...113,598,932
JBrowse link
G Usp44 ubiquitin specific peptidase 44 decreases expression ISO kojic acid results in decreased expression of USP44 mRNA CTD PMID:16595896 NCBI chr 7:28,364,169...28,412,039
Ensembl chr 7:28,364,033...28,410,053
JBrowse link
G Utp11 UTP11, small subunit processome component increases expression ISO kojic acid results in increased expression of UTP11 mRNA CTD PMID:16595896 NCBI chr 5:136,931,279...136,946,164
Ensembl chr 5:136,931,008...136,946,191
JBrowse link
G Wnt10a Wnt family member 10A decreases expression ISO kojic acid results in decreased expression of WNT10A mRNA CTD PMID:16595896 NCBI chr 9:76,349,931...76,362,400
Ensembl chr 9:76,349,931...76,362,400
JBrowse link
G Yeats2 YEATS domain containing 2 increases expression ISO kojic acid results in increased expression of YEATS2 mRNA CTD PMID:16595896 NCBI chr11:80,743,134...80,829,253
Ensembl chr11:80,743,134...80,829,208
JBrowse link
G Zc3h15 zinc finger CCCH-type containing 15 decreases expression ISO kojic acid results in decreased expression of ZC3H15 mRNA CTD PMID:16595896 NCBI chr 3:68,744,591...68,764,335
Ensembl chr 3:68,744,604...68,764,333
JBrowse link
G Zdhhc20 zinc finger DHHC-type palmitoyltransferase 20 decreases expression ISO kojic acid results in decreased expression of ZDHHC20 mRNA CTD PMID:16595896 NCBI chr15:31,980,057...32,039,006
Ensembl chr15:31,983,155...32,038,989
JBrowse link
G Zfand1 zinc finger AN1-type containing 1 decreases expression ISO kojic acid results in decreased expression of ZFAND1 mRNA CTD PMID:16595896 NCBI chr 2:91,444,431...91,457,518
Ensembl chr 2:91,444,508...91,453,246
JBrowse link
G Zfp414 zinc finger protein 414 decreases expression ISO kojic acid results in decreased expression of ZNF414 mRNA CTD PMID:16595896 NCBI chr 7:14,420,232...14,422,939
Ensembl chr 7:14,420,165...14,438,166
JBrowse link
G Zfp438 zinc finger protein 438 increases expression ISO kojic acid results in increased expression of ZNF438 mRNA CTD PMID:16595896 NCBI chr17:52,426,221...52,547,472
Ensembl chr17:52,426,221...52,547,472
JBrowse link
G Zfp483 zinc finger protein 483 decreases expression ISO kojic acid results in decreased expression of ZNF483 mRNA CTD PMID:16595896 NCBI chr 5:73,763,201...73,780,511
Ensembl chr 5:73,763,179...73,776,223
JBrowse link
G Zkscan8 zinc finger with KRAB and SCAN domains 8 decreases expression ISO kojic acid results in decreased expression of ZKSCAN8 mRNA CTD PMID:16595896 NCBI chr17:43,039,383...43,057,391
Ensembl chr17:43,039,383...43,057,391
JBrowse link
G Zmynd15 zinc finger, MYND-type containing 15 decreases expression ISO kojic acid results in decreased expression of ZMYND15 mRNA CTD PMID:16595896 NCBI chr10:55,171,198...55,177,812
Ensembl chr10:55,171,198...55,177,812
JBrowse link
G Zp2 zona pellucida glycoprotein 2 decreases expression ISO kojic acid results in decreased expression of ZP2 mRNA CTD PMID:16595896 NCBI chr 1:174,513,507...174,525,288
Ensembl chr 1:174,513,511...174,525,288
JBrowse link
lovastatin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abca1 ATP binding cassette subfamily A member 1 increases expression
decreases expression
multiple interactions
ISO Lovastatin results in increased expression of ABCA1 mRNA
lovastatin decreases expression of ABCA1 mRNA in HepG2 cells
[Dietary Fats co-treated with Lovastatin] affects the expression of ABCA1 mRNA
Lovastatin results in decreased expression of ABCA1 mRNA
CTD
RGD
PMID:19260826 PMID:29852127 PMID:27765770 RGD:18936994 NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions
decreases activity
ISO Lovastatin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
Lovastatin results in decreased activity of ABCB11 protein
CTD PMID:23956101 PMID:24014644 NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions
decreases activity
increases transport
ISO Lovastatin analog inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]
Lovastatin analog results in decreased activity of ABCB1 protein
ABCB1 protein results in increased transport of Lovastatin; ABCB1 protein results in increased transport of Lovastatin analog
CTD PMID:15616150 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 decreases activity
multiple interactions
ISO Lovastatin results in decreased activity of ABCC1 protein
[Lovastatin results in decreased activity of ABCC1 protein] which results in increased susceptibility to Antimony Sodium Gluconate; Doxorubicin inhibits the reaction [Lovastatin results in increased expression of ABCC1 mRNA]
CTD PMID:18056276 PMID:22712078 NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 multiple interactions
increases expression
decreases activity
ISO
EXP
ABCC2 protein binds to and results in increased uptake of Lovastatin analog; Lovastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Lovastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]
Lovastatin results in increased expression of ABCC2 mRNA
Lovastatin analog results in decreased activity of ABCC2 protein
ABCC2 protein binds to and results in increased uptake of Lovastatin analog; Lovastatin analog inhibits the reaction [ABCC2 protein binds to and results in increased uptake of 5(6)-carboxy-2',7'-dichlorofluorescein]; Lovastatin analog inhibits the reaction [ABCC2 protein results in increased transport of calcein AM]; Lovastatin promotes the reaction [Cisplatin results in decreased expression of ABCC2 mRNA]
CTD PMID:15616150 PMID:23562342 PMID:26739623 NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
JBrowse link
G Abcg5 ATP binding cassette subfamily G member 5 affects expression
multiple interactions
ISO Lovastatin affects the expression of ABCG5 mRNA
[Dietary Fats co-treated with Lovastatin] affects the expression of ABCG5 mRNA
CTD PMID:27208389 PMID:29852127 NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
JBrowse link
G Abcg8 ATP binding cassette subfamily G member 8 affects expression ISO Lovastatin affects the expression of ABCG8 mRNA CTD PMID:27208389 NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
JBrowse link
G Acaca acetyl-CoA carboxylase alpha multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of ACACA mRNA CTD PMID:29852127 NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
JBrowse link
G Acox1 acyl-CoA oxidase 1 multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of ACOX1 mRNA CTD PMID:29852127 NCBI chr10:101,406,197...101,431,242
Ensembl chr10:101,406,197...101,431,232
JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of ACSS2 mRNA CTD PMID:29852127 NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions
decreases expression
ISO Lovastatin inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]
Lovastatin results in decreased expression of ACTA2 protein
CTD PMID:22129737 NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
JBrowse link
G Actb actin, beta decreases expression
increases expression
ISO Lovastatin results in decreased expression of ACTB mRNA
Lovastatin results in increased expression of ACTB mRNA
CTD PMID:20493250 NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
JBrowse link
G Actr3 actin related protein 3 increases expression ISO Lovastatin results in increased expression of ACTR3 mRNA CTD PMID:20493250 NCBI chr13:36,800,739...36,843,837
Ensembl chr13:36,800,093...36,844,124
JBrowse link
G Adam10 ADAM metallopeptidase domain 10 increases expression
multiple interactions
EXP
ISO
Lovastatin results in increased expression of ADAM10 protein
[Lovastatin co-treated with APP protein] results in increased expression of ADAM10 protein
CTD PMID:29341888 NCBI chr 8:71,346,008...71,477,889
Ensembl chr 8:71,345,837...71,477,889
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing affects expression
multiple interactions
ISO Lovastatin affects the expression of ADIPOQ mRNA
[Dietary Fats co-treated with Lovastatin] affects the expression of ADIPOQ mRNA
CTD PMID:27208389 PMID:29852127 NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
JBrowse link
G Ahcy adenosylhomocysteinase decreases expression ISO Lovastatin results in decreased expression of AHCY mRNA CTD PMID:20493250 NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
JBrowse link
G Akap7 A-kinase anchoring protein 7 decreases response to substance ISO AKAP7 SNP results in decreased susceptibility to Lovastatin CTD PMID:21483694 NCBI chr 1:20,087,190...20,217,799
Ensembl chr 1:20,087,373...20,217,797
JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions
decreases phosphorylation
ISO
EXP
Lovastatin inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]
Lovastatin results in decreased phosphorylation of AKT1 protein
CTD PMID:16425225 PMID:17472962 PMID:19760159 PMID:20578043 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
JBrowse link
G Ank2 ankyrin 2 decreases response to substance ISO ANK2 SNP results in decreased susceptibility to Lovastatin CTD PMID:21483694 NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923
JBrowse link
G Anxa4 annexin A4 decreases expression ISO Lovastatin results in decreased expression of ANXA4 mRNA CTD PMID:20493250 NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
JBrowse link
G Anxa5 annexin A5 decreases expression ISO Lovastatin results in decreased expression of ANXA5 mRNA CTD PMID:20493250 NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
JBrowse link
G Apoa1 apolipoprotein A1 multiple interactions ISO [Lovastatin co-treated with Niacin] results in increased expression of APOA1 protein; [Niacin co-treated with Lovastatin] results in increased expression of APOA1 protein CTD PMID:12633795 PMID:17319473 NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
JBrowse link
G Apob apolipoprotein B multiple interactions
decreases secretion
ISO [Niacin co-treated with Lovastatin] results in decreased expression of APOB protein
Lovastatin results in decreased secretion of APOB protein
CTD PMID:11728391 PMID:12633795 NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
JBrowse link
G Apoe apolipoprotein E affects expression
multiple interactions
ISO Lovastatin affects the expression of APOE mRNA
[Dietary Fats co-treated with Lovastatin] affects the expression of APOE mRNA
CTD PMID:27208389 PMID:29852127 NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
JBrowse link
G App amyloid beta precursor protein multiple interactions
increases cleavage
increases secretion
EXP
ISO
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lovastatin results in increased secretion of APP protein modified form]; TAPI-2 inhibits the reaction [Lovastatin results in increased secretion of APP protein modified form]; U 0126 inhibits the reaction [Lovastatin results in increased secretion of APP protein]
[APP protein co-treated with Lovastatin] results in increased secretion of APP protein; [Lovastatin co-treated with APP protein] results in decreased expression of BACE1 protein; [Lovastatin co-treated with APP protein] results in increased expression of ADAM10 protein; [Lovastatin co-treated with APP protein] results in increased expression of BACE2 protein; [Lovastatin co-treated with APP protein] results in increased expression of CHRNA7 protein; [Lovastatin co-treated with APP protein] results in increased phosphorylation of MAPK1 protein; [Lovastatin co-treated with APP protein] results in increased phosphorylation of MAPK3 protein; Lovastatin affects the reaction [[MAPK1 protein co-treated with APP protein] affects the expression of APP protein]; Lovastatin affects the reaction [[MAPK1 protein co-treated with APP protein] affects the expression of CHRNA7 protein]; Lovastatin affects the reaction [[MAPK3 protein co-treated with APP protein] affects the expression of APP protein]; Lovastatin affects the reaction [[MAPK3 protein co-treated with APP protein] affects the expression of CHRNA7 protein]; U 0126 inhibits the reaction [[APP protein co-treated with Lovastatin] results in increased secretion of APP protein]; U 0126 inhibits the reaction [[Lovastatin co-treated with APP protein] results in increased expression of CHRNA7 protein]; U 0126 inhibits the reaction [[Lovastatin co-treated with APP protein] results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [[Lovastatin co-treated with APP protein] results in increased phosphorylation of MAPK3 protein]
Lovastatin results in increased cleavage of APP protein
Lovastatin results in increased secretion of APP protein; Lovastatin results in increased secretion of APP protein modified form
CTD PMID:19741129 PMID:29341888 NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
JBrowse link
G Arhgdia Rho GDP dissociation inhibitor alpha increases expression ISO Lovastatin results in increased expression of ARHGDIA mRNA CTD PMID:20493250 NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
JBrowse link
G Atm ATM serine/threonine kinase multiple interactions EXP Lovastatin inhibits the reaction [Cisplatin results in increased expression of ATM protein modified form] CTD PMID:26739623 NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
JBrowse link
G Atr ATR serine/threonine kinase multiple interactions EXP Lovastatin inhibits the reaction [Cisplatin results in increased expression of ATR protein modified form] CTD PMID:26739623 NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
JBrowse link
G Bace1 beta-secretase 1 decreases expression
multiple interactions
EXP
ISO
Lovastatin results in decreased expression of BACE1 protein
[Lovastatin co-treated with APP protein] results in decreased expression of BACE1 protein
CTD PMID:29341888 NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
JBrowse link
G Bace2 beta-secretase 2 multiple interactions
increases expression
ISO
EXP
[Lovastatin co-treated with APP protein] results in increased expression of BACE2 protein
Lovastatin results in increased expression of BACE2 protein
CTD PMID:29341888 NCBI chr11:36,707,473...36,789,550
Ensembl chr11:36,707,458...36,789,546
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions
affects localization
ISO
EXP
Lovastatin results in increased expression of BAX protein
Lovastatin promotes the reaction [Cisplatin results in increased expression of BAX mRNA]
Lovastatin affects the localization of BAX protein
CTD PMID:10473109 PMID:15180944 PMID:26739623 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
JBrowse link
G Bcar1 BCAR1 scaffold protein, Cas family member increases cleavage
multiple interactions
EXP Lovastatin results in increased cleavage of BCAR1 protein
Mevalonic Acid inhibits the reaction [Lovastatin results in increased cleavage of BCAR1 protein]
CTD PMID:16367743 NCBI chr19:39,679,218...39,713,952
Ensembl chr19:39,679,204...39,713,907
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression
multiple interactions
ISO
EXP
Lovastatin results in decreased expression of BCL2 protein
Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein]
CTD PMID:10473109 PMID:11178870 PMID:12094262 NCBI chr13:22,689,783...22,853,920 JBrowse link
G Bcl2l1 Bcl2-like 1 decreases expression
multiple interactions
EXP Lovastatin results in decreased expression of BCL2L1 protein
Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2L1 protein]
CTD PMID:11178870 NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
JBrowse link
G Bcl2l11 BCL2 like 11 multiple interactions
increases expression
ISO pyrazolanthrone inhibits the reaction [Lovastatin results in increased expression of BCL2L11 protein] CTD PMID:18766339 NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions EXP Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased expression of BDNF protein] CTD PMID:24718106 NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions
decreases expression
ISO farnesyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein]; geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] CTD PMID:17472962 PMID:18815881 NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
JBrowse link
G Brca2 BRCA2, DNA repair associated multiple interactions ISO Lovastatin inhibits the reaction [Doxorubicin results in increased expression of BRCA2 mRNA] CTD PMID:22712078 NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
JBrowse link
G C1qbp complement C1q binding protein increases expression ISO Lovastatin results in increased expression of C1QBP mRNA CTD PMID:20493250 NCBI chr10:55,699,954...55,704,605
Ensembl chr10:55,699,954...55,704,649
JBrowse link
G Calr calreticulin increases expression ISO Lovastatin results in increased expression of CALR mRNA CTD PMID:20493250 NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
JBrowse link
G Camk2b calcium/calmodulin-dependent protein kinase II beta multiple interactions EXP Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of CAMK2B protein] CTD PMID:24718106 NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994
JBrowse link
G Casp2 caspase 2 increases activity
multiple interactions
ISO Lovastatin results in increased activity of CASP2 protein
Lovastatin promotes the reaction [RHOB protein binds to CASP2 protein]
CTD PMID:12933658 PMID:16234849 NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
JBrowse link
G Casp3 caspase 3 multiple interactions
increases cleavage
increases activity
decreases expression
ISO
EXP
farnesyl pyrophosphate inhibits the reaction [Lovastatin results in increased activity of and results in increased cleavage of CASP3 protein]; geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased activity of and results in increased cleavage of CASP3 protein]
Lovastatin analog results in increased cleavage of CASP3 protein
Lovastatin results in increased activity of CASP3 protein
Lovastatin results in decreased expression of CASP3 mRNA
Lovastatin results in increased activity of and results in increased cleavage of CASP3 protein; Mevalonic Acid inhibits the reaction [Lovastatin results in increased activity of and results in increased cleavage of CASP3 protein]
CTD PMID:11720884 PMID:12933658 PMID:15180944 PMID:16367743 PMID:18034278 More... NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G Casp6 caspase 6 increases activity ISO Lovastatin results in increased activity of CASP6 protein CTD PMID:11720884 NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
JBrowse link
G Casp8 caspase 8 increases activity ISO Lovastatin results in increased activity of CASP8 protein CTD PMID:15180944 PMID:15705602 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
JBrowse link
G Casp9 caspase 9 increases activity ISO Lovastatin results in increased activity of CASP9 protein CTD PMID:12933658 PMID:15180944 PMID:15705602 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions ISO Lovastatin inhibits the reaction [Doxorubicin results in increased expression of CCN2 mRNA]; Lovastatin inhibits the reaction [Epirubicin results in increased expression of CCN2 mRNA] CTD PMID:22712078 PMID:28710503 NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
JBrowse link
G Ccnd1 cyclin D1 decreases expression
increases expression
ISO
EXP
Lovastatin results in decreased expression of CCND1 protein
Lovastatin results in increased expression of CCND1 mRNA; Lovastatin results in increased expression of CCND1 protein
CTD PMID:18034278 PMID:20578043 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
JBrowse link
G Ccnd3 cyclin D3 decreases expression ISO Lovastatin results in decreased expression of CCND3 protein CTD PMID:10502407 NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
JBrowse link
G Cct5 chaperonin containing TCP1 subunit 5 increases expression ISO Lovastatin results in increased expression of CCT5 mRNA CTD PMID:20493250 NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
JBrowse link
G Cct6a chaperonin containing TCP1 subunit 6A increases expression ISO Lovastatin results in increased expression of CCT6A mRNA CTD PMID:20493250 NCBI chr12:26,872,736...26,883,125
Ensembl chr12:26,872,574...26,883,337
JBrowse link
G Cct8 chaperonin containing TCP1 subunit 8 decreases expression ISO Lovastatin results in decreased expression of CCT8 mRNA CTD PMID:20493250 NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079
JBrowse link
G Cd40 CD40 molecule multiple interactions ISO Lovastatin inhibits the reaction [IFNG results in increased expression of CD40 mRNA] CTD PMID:17507688 NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534
JBrowse link
G Cd44 CD44 molecule (Indian blood group) decreases expression ISO Lovastatin results in decreased expression of CD44 mRNA; Lovastatin results in decreased expression of CD44 protein CTD PMID:21199873 NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
JBrowse link
G Cdc42 cell division cycle 42 increases expression
decreases expression
ISO Lovastatin results in increased expression of CDC42 protein
Lovastatin results in decreased expression of CDC42 mRNA
CTD PMID:18766339 PMID:20493250 NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111
JBrowse link
G Cdk2 cyclin dependent kinase 2 decreases activity ISO Lovastatin results in decreased activity of CDK2 protein CTD PMID:10502407 NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
JBrowse link
G Cdk4 cyclin-dependent kinase 4 decreases expression EXP Lovastatin results in decreased expression of CDK4 mRNA; Lovastatin results in decreased expression of CDK4 protein CTD PMID:20578043 NCBI chr 7:62,885,647...62,889,562
Ensembl chr 7:62,883,105...62,942,403
JBrowse link
G Cdk5 cyclin-dependent kinase 5 decreases cleavage EXP Lovastatin results in decreased cleavage of CDK5 protein CTD PMID:19741129 NCBI chr 4:10,754,682...10,760,110
Ensembl chr 4:10,754,687...10,760,112
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression
multiple interactions
ISO Lovastatin results in increased expression of CDKN1A protein
Lovastatin inhibits the reaction [Doxorubicin results in increased expression of CDKN1A mRNA]
CTD PMID:18034278 PMID:22712078 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression EXP
ISO
Lovastatin results in increased expression of CDKN1B mRNA; Lovastatin results in increased expression of CDKN1B protein CTD PMID:9848777 PMID:10502407 PMID:15118409 PMID:18034278 PMID:20578043 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 multiple interactions EXP Lovastatin inhibits the reaction [Cisplatin results in increased expression of CDKN3 protein modified form] CTD PMID:26739623 NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
JBrowse link
G Cenpf centromere protein F increases expression
multiple interactions
ISO Lovastatin results in increased expression of CENPF protein
Lovastatin promotes the reaction [Paclitaxel results in increased expression of CENPF protein]; Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of CENPF protein]
CTD PMID:12467231 NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
JBrowse link
G Cfl1 cofilin 1 decreases phosphorylation EXP Lovastatin results in decreased phosphorylation of CFL1 protein CTD PMID:20578043 NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions ISO
EXP
Lovastatin inhibits the reaction [Cisplatin results in increased phosphorylation of CHEK1 protein]; Lovastatin inhibits the reaction [Doxorubicin results in increased phosphorylation of CHEK1 protein]
Lovastatin inhibits the reaction [Cisplatin results in increased expression of CHEK1 protein modified form]
CTD PMID:17088865 PMID:21356574 PMID:26739623 NCBI chr 8:36,420,565...36,443,477 JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions EXP Lovastatin inhibits the reaction [Cisplatin results in increased expression of CHEK2 protein modified form] CTD PMID:26739623 NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit multiple interactions
increases expression
ISO
EXP
[Lovastatin co-treated with APP protein] results in increased expression of CHRNA7 protein; Lovastatin affects the reaction [[MAPK1 protein co-treated with APP protein] affects the expression of CHRNA7 protein]; Lovastatin affects the reaction [[MAPK3 protein co-treated with APP protein] affects the expression of CHRNA7 protein]; U 0126 inhibits the reaction [[Lovastatin co-treated with APP protein] results in increased expression of CHRNA7 protein]
Lovastatin results in increased expression of CHRNA7 mRNA; Lovastatin results in increased expression of CHRNA7 protein
U 0126 inhibits the reaction [Lovastatin results in increased expression of CHRNA7 protein]
CTD PMID:29341888 NCBI chr 1:116,715,286...116,837,223
Ensembl chr 1:116,714,711...116,837,240
JBrowse link
G Clic1 chloride intracellular channel 1 decreases expression ISO Lovastatin results in decreased expression of CLIC1 mRNA CTD PMID:20493250 NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
JBrowse link
G Cox5a cytochrome c oxidase subunit 5A increases expression ISO Lovastatin results in increased expression of COX5A mRNA CTD PMID:20493250 NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions EXP Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of CREB1 protein] CTD PMID:24718106 NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
JBrowse link
G Crk CRK proto-oncogene, adaptor protein increases expression ISO Lovastatin results in increased expression of CRK mRNA CTD PMID:20493250 NCBI chr10:60,530,469...60,556,703
Ensembl chr10:60,530,464...60,553,406
JBrowse link
G Ctnnb1 catenin beta 1 decreases degradation
increases expression
multiple interactions
EXP
ISO
Lovastatin results in decreased degradation of CTNNB1 protein
Lovastatin results in increased expression of CTNNB1 mRNA
Lovastatin affects the localization of and results in increased expression of CTNNB1 protein
CTD PMID:17234346 PMID:19741129 PMID:24742230 NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
increases expression
ISO Lovastatin inhibits the reaction [Doxorubicin results in increased expression of CYP1A1 mRNA]; Lovastatin results in increased expression of and results in increased activity of CYP1A1 protein
Lovastatin results in increased expression of CYP1A1 mRNA
CTD PMID:1311272 PMID:22712078 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 decreases activity ISO Lovastatin results in decreased activity of CYP2C8 protein CTD PMID:15601807
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 multiple interactions
increases expression
ISO [Lovastatin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
Lovastatin results in increased expression of CYP3A4 mRNA
CTD PMID:12505310 PMID:17041008 NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
JBrowse link
G Dctn2 dynactin subunit 2 decreases expression ISO Lovastatin results in decreased expression of DCTN2 mRNA CTD PMID:20493250 NCBI chr 7:63,092,061...63,107,560
Ensembl chr 7:63,092,057...63,108,543
JBrowse link
G Ddt D-dopachrome tautomerase decreases expression ISO Lovastatin results in decreased expression of DDT mRNA CTD PMID:20493250 NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
JBrowse link
G Dlg3 discs large MAGUK scaffold protein 3 multiple interactions EXP Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of DLG3 protein] CTD PMID:24718106 NCBI chr  X:65,859,653...65,911,887
Ensembl chr  X:65,860,172...65,910,322
JBrowse link
G Dlst dihydrolipoamide S-succinyltransferase decreases expression ISO Lovastatin results in decreased expression of DLST mRNA CTD PMID:20493250 NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296
JBrowse link
G Dock7 dedicator of cytokinesis 7 increases expression ISO Lovastatin results in increased expression of DOCK7 mRNA CTD PMID:20493250 NCBI chr 5:113,599,371...113,782,871
Ensembl chr 5:113,600,198...113,782,813
JBrowse link
G Dpysl2 dihydropyrimidinase-like 2 increases expression ISO Lovastatin results in increased expression of DPYSL2 mRNA CTD PMID:20493250 NCBI chr15:41,005,551...41,111,724
Ensembl chr15:41,005,551...41,111,829
JBrowse link
G Dstn destrin, actin depolymerizing factor decreases expression ISO Lovastatin results in decreased expression of DSTN mRNA CTD PMID:20493250 NCBI chr 3:131,284,647...131,311,361
Ensembl chr 3:131,284,648...131,311,379
JBrowse link
G Eaf2 ELL associated factor 2 decreases response to substance ISO EAF2 SNP results in decreased susceptibility to Lovastatin CTD PMID:21483694 NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
JBrowse link
G Eef2 eukaryotic translation elongation factor 2 decreases expression ISO Lovastatin results in decreased expression of EEF2 mRNA CTD PMID:20493250 NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
JBrowse link
G Egf epidermal growth factor multiple interactions ISO Lovastatin inhibits the reaction [EGF protein promotes the reaction [EGFR protein results in increased phosphorylation of EGFR protein]]; Lovastatin inhibits the reaction [EGF protein results in increased phosphorylation of AKT1 protein]; Lovastatin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; Lovastatin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; Lovastatin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; Lovastatin inhibits the reaction [EGF protein results in increased phosphorylation of RAF1 protein] CTD PMID:12942316 PMID:19760159 NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064
JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO Lovastatin inhibits the reaction [EGF protein promotes the reaction [EGFR protein results in increased phosphorylation of EGFR protein]]; Lovastatin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] CTD PMID:12942316 PMID:19760159 NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382
JBrowse link
G Eif3i eukaryotic translation initiation factor 3, subunit I decreases expression ISO Lovastatin results in decreased expression of EIF3I mRNA CTD PMID:20493250 NCBI chr 5:141,935,135...141,942,589
Ensembl chr 5:141,935,044...141,942,676
JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit increases expression
multiple interactions
EXP Lovastatin results in increased expression of ERCC1 mRNA
Lovastatin promotes the reaction [Cisplatin results in increased expression of ERCC1 mRNA]
CTD PMID:26739623 NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
JBrowse link
G Ercc5 ERCC excision repair 5, endonuclease multiple interactions
increases expression
EXP Lovastatin promotes the reaction [Cisplatin results in increased expression of ERCC5 mRNA]
Lovastatin results in increased expression of ERCC5 mRNA
CTD PMID:26739623 NCBI chr 9:46,309,477...46,354,478
Ensembl chr 9:46,309,389...46,354,472
JBrowse link
G Ercc6 ERCC excision repair 6, chromatin remodeling factor increases expression EXP Lovastatin results in increased expression of ERCC6 mRNA CTD PMID:26739623 NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
JBrowse link
G Erp29 endoplasmic reticulum protein 29 decreases expression ISO Lovastatin results in decreased expression of ERP29 mRNA CTD PMID:20493250 NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
JBrowse link
G Fads2 fatty acid desaturase 2 multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of FADS2 mRNA CTD PMID:29852127 NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
JBrowse link
G Fas Fas cell surface death receptor multiple interactions ISO Lovastatin inhibits the reaction [Doxorubicin results in increased expression of FAS mRNA] CTD PMID:17088865 NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
JBrowse link
G Faslg Fas ligand multiple interactions ISO Lovastatin inhibits the reaction [Doxorubicin results in increased expression of FASLG mRNA] CTD PMID:17088865 NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
JBrowse link
G Fasn fatty acid synthase increases expression ISO Lovastatin results in increased expression of FASN mRNA CTD PMID:11728391 NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
JBrowse link
G Fbxo32 F-box protein 32 multiple interactions
increases expression
ISO geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA]; geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein]; Lovastatin promotes the reaction [Fenofibrate results in increased expression of FBXO32 protein]; Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA]; Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of FBXO32 protein]
Lovastatin results in increased expression of FBXO32 mRNA; Lovastatin results in increased expression of FBXO32 protein
CTD PMID:19406843 PMID:33408297 NCBI chr 7:89,731,626...89,764,761
Ensembl chr 7:89,730,232...89,765,436
JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 increases activity ISO Lovastatin results in increased activity of FDFT1 protein CTD PMID:8517861 NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
JBrowse link
G Fdps farnesyl diphosphate synthase multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of FDPS mRNA CTD PMID:29852127 NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:174,486,665...174,507,776
JBrowse link
G Flot1 flotillin 1 decreases expression ISO Lovastatin results in decreased expression of FLOT1 protein CTD PMID:12628479 NCBI chr20:2,917,864...2,927,993
Ensembl chr20:2,917,137...2,927,978
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit affects expression
multiple interactions
decreases expression
EXP
ISO
Lovastatin affects the expression of FOS protein
Lovastatin inhibits the reaction [Doxorubicin results in increased expression of FOS mRNA]
Lovastatin results in decreased expression of FOS
CTD PMID:10412747 PMID:12392621 PMID:22712078 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
JBrowse link
G Fosb FosB proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP Lovastatin inhibits the reaction [benserazide, levodopa drug combination results in increased expression of FOSB protein] CTD PMID:18434508 NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
JBrowse link
G Foxo1 forkhead box O1 multiple interactions
decreases phosphorylation
ISO Lovastatin promotes the reaction [Fenofibrate results in increased expression of FOXO1 protein]
Lovastatin results in decreased phosphorylation of FOXO1 protein
CTD PMID:33034787 PMID:33408297 NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
JBrowse link
G Fscn1 fascin actin-bundling protein 1 decreases expression ISO Lovastatin results in decreased expression of FSCN1 mRNA CTD PMID:20493250 NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
JBrowse link
G G3bp1 G3BP stress granule assembly factor 1 increases expression ISO Lovastatin results in increased expression of G3BP1 mRNA CTD PMID:20493250 NCBI chr10:39,586,864...39,620,268
Ensembl chr10:39,586,864...39,620,268
JBrowse link
G G6pd glucose-6-phosphate dehydrogenase multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of G6PD mRNA CTD PMID:29852127 NCBI chr  X:152,201,081...152,220,863
Ensembl chr  X:152,201,098...152,220,801
JBrowse link
G Gale UDP-galactose-4-epimerase decreases expression ISO Lovastatin results in decreased expression of GALE mRNA CTD PMID:20493250 NCBI chr 5:148,193,886...148,198,392
Ensembl chr 5:148,194,791...148,198,388
JBrowse link
G Gap43 growth associated protein 43 increases expression ISO Lovastatin results in increased expression of GAP43 protein CTD PMID:20694854 NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045
JBrowse link
G Gdi2 GDP dissociation inhibitor 2 increases expression ISO Lovastatin results in increased expression of GDI2 mRNA CTD PMID:20493250 NCBI chr17:66,649,616...66,676,299
Ensembl chr17:66,649,619...66,676,366
JBrowse link
G Gk glycerol kinase multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of GK mRNA CTD PMID:29852127 NCBI chr  X:50,162,089...50,238,707
Ensembl chr  X:50,163,123...50,238,631
JBrowse link
G Gmps guanine monophosphate synthase increases expression ISO Lovastatin results in increased expression of GMPS mRNA CTD PMID:20493250 NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:148,435,643...148,485,875
JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions ISO [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of GPT protein; Lovastatin inhibits the reaction [Dietary Fats results in increased expression of GPT protein] CTD PMID:29852127 PMID:30853469 NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions ISO Lovastatin inhibits the reaction [Doxorubicin results in increased expression of GPX1 mRNA] CTD PMID:28710503 NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B multiple interactions EXP Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in increased expression of GRIN2B protein] CTD PMID:24718106 NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279
JBrowse link
G Gsk3b glycogen synthase kinase 3 beta decreases phosphorylation
increases phosphorylation
ISO
EXP
Lovastatin results in decreased phosphorylation of GSK3B protein
Lovastatin results in increased phosphorylation of GSK3B protein
CTD PMID:17234346 PMID:19741129 NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
JBrowse link
G H2ax H2A.X variant histone multiple interactions ISO
EXP
Lovastatin inhibits the reaction [Cisplatin results in increased phosphorylation of H2AX protein]
Lovastatin inhibits the reaction [Cisplatin results in increased expression of H2AX protein modified form]
Lovastatin inhibits the reaction [Cisplatin results in increased expression of H2AX protein modified form]; Lovastatin inhibits the reaction [Doxorubicin results in increased expression of H2AX protein modified form]; Lovastatin inhibits the reaction [Doxorubicin results in increased phosphorylation of H2AX protein]
CTD PMID:21356574 PMID:22712078 PMID:26739623 PMID:28710503 NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
JBrowse link
G Hdac1 histone deacetylase 1 increases expression ISO Lovastatin results in increased expression of HDAC1 mRNA CTD PMID:20493250 NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
JBrowse link
G Hint1 histidine triad nucleotide binding protein 1 increases expression ISO Lovastatin results in increased expression of HINT1 mRNA CTD PMID:20493250 NCBI chr10:38,989,516...38,993,259 JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase multiple interactions
affects expression
decreases activity
increases expression
ISO [Lovastatin results in decreased activity of HMGCR protein] which results in decreased abundance of farnesyl pyrophosphate; [Lovastatin results in decreased activity of HMGCR protein] which results in decreased abundance of geranylgeranyl pyrophosphate; Lovastatin inhibits the reaction [HMGCR protein results in increased abundance of geranyl diphosphate]
[Dietary Fats co-treated with Lovastatin] affects the expression of HMGCR mRNA
Lovastatin affects the expression of HMGCR mRNA
Lovastatin results in increased expression of HMGCR mRNA
CTD PMID:8517861 PMID:8593127 PMID:17208200 PMID:19260826 PMID:19699819 More... NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of HMGCS1 mRNA CTD PMID:29852127 NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
JBrowse link
G Hmox1 heme oxygenase 1 increases expression
multiple interactions
ISO Lovastatin results in increased expression of HMOX1 protein
Lovastatin inhibits the reaction [Doxorubicin results in increased expression of HMOX1 mRNA]
CTD PMID:20594940 PMID:21910007 PMID:28710503 NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
JBrowse link
G Hnrnpab heterogeneous nuclear ribonucleoprotein A/B increases expression ISO Lovastatin results in increased expression of HNRNPAB mRNA CTD PMID:20493250 NCBI chr10:35,857,040...35,862,935
Ensembl chr10:35,857,041...35,863,344
JBrowse link
G Hnrnpdl heterogeneous nuclear ribonucleoprotein D-like decreases expression ISO Lovastatin results in decreased expression of HNRNPDL mRNA CTD PMID:20493250 NCBI chr14:9,558,079...9,563,654
Ensembl chr14:9,557,425...9,562,506
JBrowse link
G Hnrnpf heterogeneous nuclear ribonucleoprotein F increases expression ISO Lovastatin results in increased expression of HNRNPF mRNA CTD PMID:20493250 NCBI chr 4:151,083,262...151,104,464
Ensembl chr 4:151,083,062...151,109,038
JBrowse link
G Hnrnpk heterogeneous nuclear ribonucleoprotein K decreases expression
increases expression
ISO Lovastatin results in decreased expression of HNRNPK mRNA
Lovastatin results in increased expression of HNRNPK mRNA
CTD PMID:20493250 NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997
JBrowse link
G Hras HRas proto-oncogene, GTPase decreases prenylation
multiple interactions
ISO Lovastatin results in decreased prenylation of HRAS protein
Lovastatin results in decreased prenylation of and results in decreased localization of HRAS protein
CTD PMID:16156861 PMID:19360310 NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 decreases expression ISO Lovastatin results in decreased expression of HSP90AB1 mRNA CTD PMID:20493250 NCBI chr 9:15,432,986...15,438,358
Ensembl chr 9:15,433,691...15,438,488
JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 increases expression ISO Lovastatin results in increased expression of HSPA8 mRNA CTD PMID:20493250 NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 increases expression ISO Lovastatin results in increased expression of HSPD1 mRNA CTD PMID:20493250 NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662
JBrowse link
G Ifng interferon gamma multiple interactions ISO Lovastatin inhibits the reaction [IFNG results in increased expression of CD40 mRNA] CTD PMID:17507688 NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
JBrowse link
G Igf1 insulin-like growth factor 1 decreases response to substance ISO IGF1 protein results in decreased susceptibility to Lovastatin CTD PMID:9525472 NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
JBrowse link
G Igf1r insulin-like growth factor 1 receptor multiple interactions EXP Lovastatin promotes the reaction [INS protein results in increased phosphorylation of IGF1R protein] CTD PMID:19741129 NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777
JBrowse link
G Il18 interleukin 18 multiple interactions ISO [Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein; geraniol inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein]; geraniol promotes the reaction [lonafarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein]]; geraniol promotes the reaction [manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein]]; geraniol promotes the reaction [tipifarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein]]; lonafarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein]; manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein]; tipifarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL18 protein] CTD PMID:21430599 NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein; geraniol inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]; geraniol promotes the reaction [lonafarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]]; geraniol promotes the reaction [manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]]; geraniol promotes the reaction [tipifarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]]; lonafarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]; Lovastatin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; manumycin inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein]; tipifarnib inhibits the reaction [[Alendronate co-treated with Lovastatin co-treated with lipopolysaccharide, E coli O55-B5] results in increased secretion of IL1B protein] CTD PMID:18809656 PMID:21430599 NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
JBrowse link
G Il6 interleukin 6 multiple interactions ISO Lovastatin inhibits the reaction [Doxorubicin results in increased expression of IL6 mRNA] CTD PMID:28710503 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
JBrowse link
G Ins2 insulin 2 multiple interactions EXP Lovastatin promotes the reaction [INS protein results in increased phosphorylation of IGF1R protein]; Lovastatin promotes the reaction [INS protein results in increased phosphorylation of INSR protein] CTD PMID:19741129 NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
JBrowse link
G Insig1 insulin induced gene 1 increases expression
multiple interactions
ISO Lovastatin results in increased expression of INSIG1 mRNA
[Dietary Fats co-treated with Lovastatin] affects the expression of INSIG1 mRNA
CTD PMID:19260826 PMID:29852127 NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
JBrowse link
G Insig2 insulin induced gene 2 multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of INSIG2 mRNA CTD PMID:29852127 NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
JBrowse link
G Insr insulin receptor multiple interactions EXP Lovastatin promotes the reaction [INS protein results in increased phosphorylation of INSR protein] CTD PMID:19741129 NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
JBrowse link
G Ipo5 importin 5 decreases expression ISO Lovastatin results in decreased expression of IPO5 mRNA CTD PMID:20493250 NCBI chr15:97,990,755...98,041,074
Ensembl chr15:98,005,299...98,041,126
JBrowse link
G Irf4 interferon regulatory factor 4 decreases expression ISO Lovastatin results in decreased expression of IRF4 protein CTD PMID:33034787 NCBI chr17:33,721,800...33,742,570
Ensembl chr17:33,721,811...33,740,070
JBrowse link
G Irs1 insulin receptor substrate 1 multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of IRS1 mRNA CTD PMID:29852127 NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
JBrowse link
G Irs2 insulin receptor substrate 2 multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of IRS2 mRNA CTD PMID:29852127 NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
JBrowse link
G Isyna1 inositol-3-phosphate synthase 1 increases expression ISO Lovastatin results in increased expression of ISYNA1 mRNA CTD PMID:20493250 NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
JBrowse link
G Itgb1 integrin subunit beta 1 decreases expression ISO Lovastatin results in decreased expression of ITGB1 protein CTD PMID:12405293 NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit affects expression
multiple interactions
decreases expression
EXP
ISO
Lovastatin affects the expression of JUN protein
Lovastatin inhibits the reaction [Doxorubicin results in increased expression of JUN mRNA]
Lovastatin results in decreased expression of JUN
CTD PMID:10412747 PMID:12392621 PMID:22712078 NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
JBrowse link
G Kcnh2 potassium voltage-gated channel subfamily H member 2 affects activity ISO Lovastatin affects the activity of KCNH2 protein CTD PMID:16278312 NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
JBrowse link
G Kras KRAS proto-oncogene, GTPase decreases prenylation
increases expression
affects localization
increases activity
ISO Lovastatin results in decreased prenylation of KRAS protein
Lovastatin results in increased expression of KRAS protein
Lovastatin affects the localization of KRAS protein
Lovastatin results in increased activity of KRAS protein
CTD PMID:12106604 PMID:12907238 PMID:16156861 PMID:17005160 NCBI chr 4:178,185,418...178,218,484 JBrowse link
G Krt18 keratin 18 decreases expression ISO Lovastatin results in decreased expression of KRT18 mRNA CTD PMID:20493250 NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
JBrowse link
G Lasp1 LIM and SH3 protein 1 decreases expression ISO Lovastatin results in decreased expression of LASP1 mRNA CTD PMID:20493250 NCBI chr10:82,795,177...82,835,659
Ensembl chr10:82,795,137...82,943,292
JBrowse link
G Lcn2 lipocalin 2 multiple interactions ISO [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of LCN2 mRNA CTD PMID:30853469 NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
JBrowse link
G Ldlr low density lipoprotein receptor multiple interactions
increases activity
increases expression
ISO
EXP
OSM protein promotes the reaction [Lovastatin results in increased expression of LDLR mRNA]
[Dietary Fats co-treated with Lovastatin] affects the expression of LDLR mRNA
[Cholesterol deficiency co-treated with Lovastatin] results in increased expression of LDLR mRNA; Cholesterol inhibits the reaction [[Cholesterol deficiency co-treated with Lovastatin] results in increased expression of LDLR mRNA]
Lovastatin results in increased activity of LDLR protein
CTD PMID:8593127 PMID:11728391 PMID:12524230 PMID:20578043 PMID:29852127 NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
JBrowse link
G Lef1 lymphoid enhancer binding factor 1 affects localization ISO Lovastatin affects the localization of LEF1 protein CTD PMID:17234346 NCBI chr 2:219,666,549...219,779,815
Ensembl chr 2:219,666,592...219,779,794
JBrowse link
G Lipc lipase C, hepatic type affects expression ISO Lovastatin affects the expression of LIPC mRNA CTD PMID:27208389 NCBI chr 8:71,509,633...71,635,663
Ensembl chr 8:71,509,635...71,635,464
JBrowse link
G Lmnb1 lamin B1 decreases farnesylation
increases degradation
affects localization
ISO Lovastatin results in decreased farnesylation of LMNB1 protein
Lovastatin results in increased degradation of LMNB1 protein
Lovastatin affects the localization of LMNB1 protein
CTD PMID:10203554 PMID:11720884 NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502
JBrowse link
G Lpin2 lipin 2 decreases response to substance ISO LPIN2 SNP results in decreased susceptibility to Lovastatin CTD PMID:21483694 NCBI chr 9:111,083,378...111,158,193
Ensembl chr 9:111,083,745...111,158,193
JBrowse link
G Lpl lipoprotein lipase affects expression
multiple interactions
ISO Lovastatin affects the expression of LPL mRNA
[Dietary Fats co-treated with Lovastatin] affects the expression of LPL mRNA
CTD PMID:27208389 PMID:29852127 NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
JBrowse link
G Lrp5 LDL receptor related protein 5 increases expression ISO Lovastatin results in increased expression of LRP5 mRNA CTD PMID:24742230 NCBI chr 1:200,814,247...200,917,581
Ensembl chr 1:200,814,250...200,917,581
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation
decreases activity
decreases phosphorylation
EXP
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lovastatin results in decreased phosphorylation of MAPK1 protein]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Lovastatin results in decreased phosphorylation of MAPK1 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK1 protein]; Lovastatin inhibits the reaction [Phenylephrine results in increased phosphorylation of MAPK1 protein]; Mevalonic Acid inhibits the reaction [Lovastatin results in decreased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [Lovastatin results in increased phosphorylation of MAPK1 protein]
Lovastatin results in decreased activity of MAPK1 protein
[Lovastatin co-treated with APP protein] results in increased phosphorylation of MAPK1 protein; Lovastatin affects the reaction [[MAPK1 protein co-treated with APP protein] affects the expression of APP protein]; Lovastatin affects the reaction [[MAPK1 protein co-treated with APP protein] affects the expression of CHRNA7 protein]; Lovastatin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [[Lovastatin co-treated with APP protein] results in increased phosphorylation of MAPK1 protein]
CTD PMID:12213976 PMID:16952276 PMID:19360310 PMID:19760159 PMID:20578043 More... NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation
decreases activity
decreases phosphorylation
ISO
EXP
[Lovastatin co-treated with APP protein] results in increased phosphorylation of MAPK3 protein; Lovastatin affects the reaction [[MAPK3 protein co-treated with APP protein] affects the expression of APP protein]; Lovastatin affects the reaction [[MAPK3 protein co-treated with APP protein] affects the expression of CHRNA7 protein]; Lovastatin inhibits the reaction [EGF protein results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [[Lovastatin co-treated with APP protein] results in increased phosphorylation of MAPK3 protein]
Lovastatin results in increased phosphorylation of MAPK3 protein
Lovastatin results in decreased activity of MAPK3 protein
Lovastatin results in decreased phosphorylation of MAPK3 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Lovastatin results in decreased phosphorylation of MAPK3 protein]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Lovastatin results in decreased phosphorylation of MAPK3 protein]; Lovastatin inhibits the reaction [[Oxygen deficiency co-treated with Carbon Dioxide] results in decreased phosphorylation of MAPK3 protein]; Lovastatin inhibits the reaction [benserazide, levodopa drug combination results in increased phosphorylation of MAPK3 protein]; Mevalonic Acid inhibits the reaction [Lovastatin results in decreased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [Lovastatin results in increased phosphorylation of MAPK3 protein]
CTD PMID:16952276 PMID:18434508 PMID:19360310 PMID:19760159 PMID:20578043 More... NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions EXP Lovastatin inhibits the reaction [Cisplatin results in increased expression of MAPK8 protein modified form] CTD PMID:26739623 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
JBrowse link
G Mapk9 mitogen-activated protein kinase 9 multiple interactions EXP Lovastatin inhibits the reaction [Cisplatin results in increased expression of MAPK9 protein modified form] CTD PMID:26739623 NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
JBrowse link
G Mbp myelin basic protein multiple interactions
increases expression
EXP 2-chloro-5-nitrobenzanilide inhibits the reaction [Lovastatin results in increased expression of MBP mRNA]; geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of MBP mRNA]; PPARG protein affects the reaction [Lovastatin results in increased expression of MBP mRNA]; PTEN protein affects the reaction [Lovastatin results in increased expression of MBP mRNA] CTD PMID:20578043 NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
JBrowse link
G Mfn2 mitofusin 2 multiple interactions ISO Lovastatin inhibits the reaction [Doxorubicin results in increased expression of MFN2 mRNA] CTD PMID:28710503 NCBI chr 5:158,304,285...158,335,502
Ensembl chr 5:158,304,287...158,335,342
JBrowse link
G Mir133b microRNA 133b multiple interactions ISO [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of MIR133B mRNA CTD PMID:30853469 NCBI chr 9:23,098,134...23,098,217
Ensembl chr 9:23,098,134...23,098,217
JBrowse link
G Mir206 microRNA 206 multiple interactions ISO [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of MIR206 mRNA CTD PMID:30853469 NCBI chr 9:23,094,249...23,094,332
Ensembl chr 9:23,094,249...23,094,332
JBrowse link
G Mmp2 matrix metallopeptidase 2 decreases expression ISO Lovastatin results in decreased expression of MMP2 protein CTD PMID:19360310 NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
JBrowse link
G Mmp3 matrix metallopeptidase 3 multiple interactions ISO Lovastatin inhibits the reaction [Doxorubicin results in increased expression of MMP3 mRNA] CTD PMID:28710503 NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
JBrowse link
G Mmp9 matrix metallopeptidase 9 decreases expression ISO Lovastatin results in decreased expression of MMP9 protein CTD PMID:19360310 NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
JBrowse link
G Mstn myostatin increases expression ISO Lovastatin results in increased expression of MSTN protein CTD PMID:33034787 NCBI chr 9:48,453,982...48,458,809
Ensembl chr 9:48,452,533...48,458,933
JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 multiple interactions ISO Doxorubicin inhibits the reaction [Lovastatin results in increased expression of NFE2L2 mRNA]; Lovastatin inhibits the reaction [Doxorubicin results in increased expression of NFE2L2 mRNA] CTD PMID:22712078 PMID:28710503 NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
JBrowse link
G Nmral1 NmrA like redox sensor 1 increases expression ISO Lovastatin results in increased expression of NMRAL1 mRNA CTD PMID:20493250 NCBI chr10:10,841,693...10,850,199
Ensembl chr10:10,841,799...10,850,192
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO Lovastatin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] CTD PMID:18809656 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
JBrowse link
G Nppa natriuretic peptide A multiple interactions ISO Lovastatin inhibits the reaction [Doxorubicin results in increased expression of NPPA mRNA] CTD PMID:28710503 NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:158,429,042...158,430,351
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression ISO Lovastatin results in increased expression of NQO1 mRNA CTD PMID:1311272 NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO [Lovastatin results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA CTD PMID:17041008 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
JBrowse link
G Nras NRAS proto-oncogene, GTPase decreases prenylation ISO Lovastatin results in decreased prenylation of NRAS protein CTD PMID:16156861 NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
JBrowse link
G Nucb1 nucleobindin 1 increases expression ISO Lovastatin results in increased expression of NUCB1 mRNA CTD PMID:20493250 NCBI chr 1:95,968,325...95,999,183
Ensembl chr 1:95,968,326...96,003,220
JBrowse link
G Oat ornithine aminotransferase decreases expression ISO Lovastatin results in decreased expression of OAT mRNA CTD PMID:20493250 NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
JBrowse link
G Osm oncostatin M multiple interactions ISO OSM protein promotes the reaction [Lovastatin results in increased expression of LDLR mRNA] CTD PMID:12524230 NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
JBrowse link
G Pa2g4 proliferation-associated 2G4 increases expression ISO Lovastatin results in increased expression of PA2G4 mRNA CTD PMID:20493250 NCBI chr 7:984,795...992,264
Ensembl chr 7:983,971...992,331
JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 increases cleavage ISO Lovastatin analog results in increased cleavage of PARP1 protein CTD PMID:26863638 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
JBrowse link
G Parvb parvin, beta decreases response to substance ISO PARVB SNP results in decreased susceptibility to Lovastatin CTD PMID:21483694 NCBI chr 7:115,360,254...115,445,767
Ensembl chr 7:115,360,261...115,445,766
JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 multiple interactions ISO [Dietary Fats co-treated with Lovastatin] affects the expression of PCK1 mRNA CTD PMID:29852127 NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
JBrowse link
G Pdgfra platelet derived growth factor receptor alpha decreases expression EXP Lovastatin results in decreased expression of PDGFRA mRNA CTD PMID:20578043 NCBI chr14:33,005,838...33,054,347
Ensembl chr14:33,005,839...33,054,335
JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 decreases expression
increases expression
ISO Lovastatin results in decreased expression of PDIA3 mRNA
Lovastatin results in increased expression of PDIA3 mRNA
CTD PMID:20493250 NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236
JBrowse link
G Pdia4 protein disulfide isomerase family A, member 4 decreases expression ISO Lovastatin results in decreased expression of PDIA4 mRNA CTD PMID:20493250 NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
JBrowse link
G Pgam1 phosphoglycerate mutase 1 decreases expression
increases expression
ISO Lovastatin results in decreased expression of PGAM1 mRNA
Lovastatin results in increased expression of PGAM1 mRNA
CTD PMID:20493250 NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
JBrowse link
G Pkm pyruvate kinase M1/2 decreases expression ISO Lovastatin results in decreased expression of PKM mRNA CTD PMID:20493250 NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
JBrowse link
G Pla2g4a phospholipase A2 group IVA increases expression EXP Lovastatin results in increased expression of PLA2G4A mRNA CTD PMID:20578043 NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
JBrowse link
G Plat plasminogen activator, tissue type multiple interactions
increases secretion
increases expression
EXP
ISO
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PLAT protein]; Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of PLAT protein]
Lovastatin results in increased secretion of PLAT protein
CTD PMID:10412747 PMID:12405293 NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
JBrowse link
G Plau plasminogen activator, urokinase decreases secretion ISO Lovastatin results in decreased secretion of PLAU protein CTD PMID:12405293 NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
JBrowse link
G Pon3 paraoxonase 3 increases hydrolysis
increases metabolic processing
multiple interactions
ISO PON3 protein results in increased hydrolysis of Lovastatin
PON3 protein results in increased metabolism of Lovastatin
7-ketocholesterol inhibits the reaction [PON3 protein results in increased metabolism of Lovastatin]; Phosphatidylcholines inhibits the reaction [PON3 protein results in increased metabolism of Lovastatin]
CTD PMID:12615656 PMID:15772423 NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions
affects localization
increases expression
ISO
EXP
2-chloro-5-nitrobenzanilide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein]; PPARG protein affects the reaction [Lovastatin results in increased expression of PTEN protein]
geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA]; Lovastatin results in increased expression of and affects the localization of PPARG protein; Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA]; PPARG protein affects the reaction [Lovastatin results in increased expression of MBP mRNA]; PPARG protein affects the reaction [Lovastatin results in increased expression of SOX10 mRNA]
[Dietary Fats co-treated with Lovastatin] affects the expression of PPARG mRNA; PPARG affects the reaction [Lovastatin results in increased expression of PTEN protein]
CTD PMID:16425225 PMID:20578043 PMID:26863638 PMID:29852127 NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
JBrowse link
G Ppargc1a PPARG coactivator 1 alpha multiple interactions ISO Lovastatin inhibits the reaction [Doxorubicin results in increased expression of PPARGC1A mRNA] CTD PMID:28710503 NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
JBrowse link
G Ppp1ca protein phosphatase 1 catalytic subunit alpha decreases expression ISO Lovastatin results in decreased expression of PPP1CA mRNA CTD PMID:20493250 NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
JBrowse link
G Ppp2r1a protein phosphatase 2 scaffold subunit A alpha increases expression ISO Lovastatin results in increased expression of PPP2R1A mRNA CTD PMID:20493250 NCBI chr 1:60,540,223...60,559,467
Ensembl chr 1:60,540,194...60,560,129
JBrowse link
G Prkcd protein kinase C, delta multiple interactions
increases cleavage
EXP benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone inhibits the reaction [Lovastatin results in increased cleavage of PRKCD protein]; Mevalonic Acid inhibits the reaction [Lovastatin results in increased cleavage of PRKCD protein] CTD PMID:16367743 NCBI chr16:5,769,226...5,807,214
Ensembl chr16:5,769,215...5,799,352
JBrowse link
G Psma3 proteasome 20S subunit alpha 3 decreases expression ISO Lovastatin results in decreased expression of PSMA3 mRNA CTD PMID:20493250 NCBI chr 6:89,483,741...89,503,775
Ensembl chr 6:89,483,727...89,504,965
JBrowse link
G Psma6 proteasome 20S subunit alpha 6 decreases expression ISO Lovastatin results in decreased expression of PSMA6 mRNA CTD PMID:20493250 NCBI chr 6:72,765,534...72,796,554
Ensembl chr 6:72,765,473...72,796,554
JBrowse link
G Psmc2 proteasome 26S subunit, ATPase 2 decreases expression ISO Lovastatin results in decreased expression of PSMC2 mRNA CTD PMID:20493250 NCBI chr 4:13,255,851...13,270,102
Ensembl chr 4:13,255,856...13,270,185
JBrowse link
G Pten phosphatase and tensin homolog multiple interactions
increases expression
ISO
EXP
Cycloheximide inhibits the reaction [Lovastatin results in increased expression of PTEN protein]; PPARG protein affects the reaction [Lovastatin results in increased expression of PTEN protein]
2-chloro-5-nitrobenzanilide inhibits the reaction [Lovastatin results in increased expression of PTEN mRNA]; geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PTEN mRNA]; Lovastatin results in increased expression of and results in increased phosphorylation of PTEN protein; PTEN protein affects the reaction [Lovastatin results in increased expression of MBP mRNA]; PTEN protein affects the reaction [Lovastatin results in increased expression of SOX10 mRNA]
PPARG affects the reaction [Lovastatin results in increased expression of PTEN protein]
CTD PMID:16425225 PMID:20578043 NCBI chr 1:230,631,303...230,696,754
Ensembl chr 1:230,630,338...230,696,838
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 decreases expression
increases expression
multiple interactions
ISO
EXP
Lovastatin results in decreased expression of PTGS2 protein
Lovastatin analog results in increased expression of PTGS2 mRNA; Lovastatin analog results in increased expression of PTGS2 protein
Mevalonic Acid affects the reaction [Lovastatin analog results in increased expression of PTGS2 protein]
Lovastatin results in increased expression of PTGS2 mRNA; Lovastatin results in increased expression of PTGS2 protein
CTD PMID:20578043 PMID:21910007 PMID:26863638 NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
JBrowse link
G Rab1a RAB1A, member RAS oncogene family decreases expression ISO Lovastatin results in decreased expression of RAB1A mRNA CTD PMID:20493250 NCBI chr14:94,422,219...94,448,799
Ensembl chr14:94,415,275...94,448,248
JBrowse link
G Rac1 Rac family small GTPase 1 multiple interactions
affects localization
decreases activity
increases expression
ISO geranylgeraniol inhibits the reaction [Lovastatin affects the localization of RAC1 protein]; Mevalonic Acid inhibits the reaction [Lovastatin affects the localization of RAC1 protein]
Lovastatin results in decreased activity of RAC1 protein
Lovastatin results in increased expression of RAC1 protein
CTD PMID:12933658 PMID:18766339 PMID:19360310 PMID:21356574 NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase multiple interactions
decreases activity
ISO Lovastatin inhibits the reaction [EGF protein results in increased phosphorylation of RAF1 protein]
Lovastatin results in decreased activity of RAF1 protein
CTD PMID:19360310 PMID:19760159 NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317
JBrowse link
G Rap1a RAP1A, member of RAS oncogene family increases expression ISO Lovastatin results in increased expression of RAP1A protein CTD PMID:12467231 NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
JBrowse link
G Rb1 RB transcriptional corepressor 1 decreases phosphorylation EXP
ISO
Lovastatin results in decreased phosphorylation of RB1 protein CTD PMID:9848777 PMID:10502407 PMID:15118409 NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
JBrowse link
G Rhoa ras homolog family member A multiple interactions
decreases expression
decreases prenylation
affects localization
ISO
EXP
geranylgeraniol inhibits the reaction [Lovastatin affects the localization of RHOA p